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A B S T R A C T
Background
Many women would like to have a choice in pain relief during labour and also would like to avoid invasive methods of pain management
in labour. Inhaled analgesia during labour involves the self-administered inhalation of sub-anaesthetic concentrations of agents while
the mother remains awake and her protective laryngeal reflexes remain intact. Most of the agents are easy to administer, can be started
in less than a minute and become effective within a minute.
Objectives
To examine the effects of all modalities of inhaled analgesia on the mother and the newborn for mothers who planned to have a vaginal
delivery.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (31 January 2012), ClinicalTrials.gov, and Current
Controlled Trials (2 June 2012), handsearched conference proceedings from the American Society of Clinical Anesthesia (from 1990
to 2011), contacted content experts and trialists and searched reference lists of retrieved studies.
Selection criteria
Randomised controlled trials comparing inhaled analgesia with other inhaled analgesia or placebo or no treatment or other methods
of non-pharmacological pain management in labour.
Data collection and analysis
Review authors independently assessed trials for eligibility, methodological quality and extracted all data. Data were double checked
for accuracy.
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Main results
Twenty-six studies, randomising 2959 women, were included in this review.
Inhaled analgesia versus a different type of inhaled analgesia
Pain relief was measured using a Visual Analogue Scale (VAS) from 0 to 100 mm where 100 corresponds to the most relief. Pain
intensity was measured using a VAS from 0 to 100 mm, where 0 corresponds to no pain at all and 100 corresponds to the worst pain.
The highest score for pain relief is the most positive in contrast to ’pain intensity’ in which the higher score is more negative.
Flurane derivatives were found to offer better pain relief than nitrous oxide in first stage of labour as measured by a lower pain intensity
score (average mean difference (MD) 14.39, 95% confidence interval (CI) 4.41 to 24.37, three studies, 70 women), also a higher pain
relief score for flurane derivatives compared with nitrous oxide (average MD -16.32, 95% CI -26.85 to -5.79, two studies, 70 women).
Substantial heterogeneity was found in the analyses of pain intensity (P = 0.003) and in the analysis of pain relief (P = 0.002).These
findings should be considered with caution because of the questionable design of the included cross-over trials. More nausea was found
in the nitrous oxide group compared with the flurane derivatives group (risk ratio (RR) 6.60 95% CI 1.85 to 23.52, two studies, 98
women).
Inhaled analgesia versus placebo or no treatment
Placebo or no treatment was found to offer less pain relief compared to nitrous oxide (average RR 0.06, 95% CI 0.01 to 0.34, two
studies, 310 women; MD -3.50, 95% CI -3.75 to -3.25, one study, 509 women). However, nitrous oxide resulted in more side effects
for women such as nausea (RR 43.10, 95% CI 2.63 to 706.74, one study, 509 women), vomiting (RR 9.05, 95% CI 1.18 to 69.32,
two studies, 619 women), dizziness (RR 113.98, 95% CI 7.09 to 1833.69, one study, 509 women) and drowsiness (RR 77.59, 95%
CI 4.80 to 1254.96, one study, 509 women) when compared with placebo or no treatment.
There were no significant differences found for any of the outcomes in the studies comparing one strength versus a different strength
of inhaled analgesia, in studies comparing different delivery systems or in the study comparing inhaled analgesia with TENS.
Due to lack of data, the following outcomes were not analysed within the review: sense of control; satisfaction with childbirth experience;
effect on mother/baby interaction; breastfeeding; admission to special care baby unit; poor infant outcomes at long-term follow-up; or
costs.
Authors’ conclusions
Inhaled analgesia appears to be effective in reducing pain intensity and in giving pain relief in labour. However, substantial heterogeneity
was detected for pain intensity. Furthermore, nitrous oxide appears to result in more side effects compared with flurane derivatives.
Flurane derivatives result inmore drowsiness when compared with nitrous oxide.When inhaled analgesia is compared with no treatment
or placebo, nitrous oxide appears to result in even more side effects such as nausea, vomiting, dizziness and drowsiness. There is no
evidence for differences for any of the outcomes comparing one strength verus a different strength of inhaled analgesia, comparing
different delivery systems or comparing inhaled analgesia with TENS.
P L A I N L A N G U A G E S U M M A R Y
Inhaled analgesia for relieving pain during labour
Labour pain and methods to relieve it are major concerns for pregnant women, healthcare workers and the general public. These
concerns have implications for the course of labour, for the quality of maternal and infant outcomes as well as for the costs of obstetric
health care.
Women in labour who need pain relief should not only have access to invasive methods such as an epidural, which may have considerable
side effects, but other means of pain relief as well. Futhermore, even in hospitals with full-time obstetric anaesthesia coverage no one
may be available to give an epidural, and in primary care, invasive methods for pain relief are not available at all.
All women in labour should have the opportunity to choose some non-invasive method of relatively effective and safe analgesia at short
notice when they wish it during labour. Inhaled pain relief, such as nitrous oxide and some flurane derivatives, may be a very useful
additional method for pain relief. It is relatively easy to administer, can be started in less than a minute, and become effective within a
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minute. Nitrous oxide is more widely known and used as inhaled pain relief during labour compared to flurane derivatives, probably
due to the availability of safe equipment, no pungent smell and the ease of administration.
In this review of 26 randomised controlled trials of 2959 women, the effectiveness and safety of inhaled analgesia as pain relief for
women in labour were studied. It was found that inhaled analgesia may help relieve pain during labour but women have to be informed
about the side effects, such as nausea, vomiting, dizziness and drowsiness.
Inhaled analgesia may help relieve labour pain without adversely increasing operative delivery rates (forceps or vacuum extraction,
caesarian section), or affecting neonatal well being. Flurane derivatives were found to be slightly more effective than nitrous oxide for
the reduction of pain and for pain relief although nitrous oxide also helped to relieve pain when compared with no treatment.
Women who used nitrous oxide were more likely to experience nausea compared with flurane derivatives. When nitrous oxide was
compared with no treatment or placebo, nitrous oxide resulted in side effects such as nausea, vomiting, dizziness and drowsiness.
There was no information for satisfaction with childbirth experience or sense of control in labour in these studies and further research
on these two important outcomes would be helpful.
B A C K G R O U N D
Description of the condition
Labour pain and methods to relieve it are major concerns for
women, healthcare workers and the general public (Caton 2002).
These concerns have implications for the course of labour, for
the quality of maternal and infant obstetric outcomes as well as
for the costs of obstetric health care. In our modern society, pain
has a negative connotation for the general public. Fear of labour
pain is strongly associated with the fear of pain in general (Lowe
2002; Rosen 2002). Different views about the importance of pain
during labour are reflected in great differences between countries
worldwide with regard to the numbers of women who receive pain
relief during labour, aswell as the type of pharmacological analgesia
that is used. Culture plays a significant role in attitudes towards
childbirth pain, the definition of the meaning of childbirth pain,
perceptions of pain and coping mechanisms used to manage pain
in childbirth.
Description of the intervention
Inhaled analgesia during labour involves the inhalation of sub-
anaesthetic concentrations of agents while the mother remains
awake and her protective laryngeal reflexes remain intact. The use
of inhaled analgesics for pain relief during labour dates back to
1847, when James Simpson used it for the first time for vaginal de-
livery (Rae 1997).Nitrous oxidewas first used in 1881by Stanislaw
Klikovich, who studied the effects of pre-mixed nitrous oxide 80%
in oxygen on women in labour (Richards 1976). In 1934, Min-
nitt introduced an apparatus for the self-administration of nitrous
oxide (Minnitt 1934). Other possibilities for inhaled analgesia for
pain relief in labour are isoflurane, sevoflurane, trichloroethylene
in air, methoxyflurane and cyclopropane. Trichloroethylene can-
not be administered through a CO2 absorber and is flammable,
while cyclopropane is explosive even in sub-anaesthetic concentra-
tions. Both drugs are no longer used in the developed world and
therefore must be seen as of historical interest only. Sevoflurane is
not recommended as analgesia because it has no analgesic activ-
ity at sub-anaesthetic concentrations. Sub-anaesthetic concentra-
tions of nitrous oxide, enflurane, isoflurane and methoxyflurane
do not significantly decrease uterine contractions and are prefer-
able for this reason. However, only the use of nitrous oxide is
widespread in modern obstetric practice. The reason why is not
clear but probably due to ease of administration, lack of flamma-
bility, lack of pungent odour, lack of effect on uterine contrac-
tions, lack of relation with pathologic temperature, minimal toxic-
ity and minimal depression of the cardio-vascular system (KNOV
2009; Rosen 2002). The evidence on the use of nitrous oxide for
relief of labour pain has been summarised in a systematic review
(Rosen 2002). Nitrous oxide mixed with oxygen as labour pain
management in labour is self-administered by labouring women
by inhalation through a mouthpiece or facemask. Entonox is a
trade marked name for a mix of 50% nitrous oxide and 50% oxy-
gen in liquid state in a single pressured container. Alternatively,
Entonox can be used by blending a fixed concentration of 50%
nitrous oxide and 50% oxide by two separate cylinders or hospital
pipeline supply; the distribution of Entonox is carried out through
a small regulator apparatus (Nitronox™). The Midogas device is
another way to inhale Entonox which allows adjustment of the
nitrous oxide concentration within a narrow range. The cylinders
are connected to a facemask or mouthpiece. The demand valve
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opens only when the user applies a negative pressure by inspiring
through the mouthpiece or well-sealed mask covering the parturi-
ent’s mouth and nose. The demand valve eliminates flow when
the parturient is not inhaling to minimise environmental contam-
ination. Unlike the Entonox apparatus, the Nitronox apparatus
allows exhaled gas to be scavenged. In countries such as Canada,
Denmark, Finland, New Zealand, the United Kingdom and the
United States of America, midwives are allowed to 1) set up the
equipment for nitrous oxide, 2) instruct the woman how to use
it and 3) monitor her use of it. The woman can self-administer
it after initial supervision. Inhaled analgesia can be used by the
woman either intermittently with discontinuation of use as the
contraction pain eases or disappears, or continuously, by inhaling
both during and between contractions. There is a rapid uptake/
washout rate for most of the inhaled analgesia, which means a low
blood/gas solubility ratio. The blood/gas solubility ratio for ni-
trous oxide is 0.47 at 37 degrees C; for Isoflurane: 1.4; for Sevoflu-
rane: 0.69; for Enflurane: 1.64 and for Methoxuyflurane: 13. For
Methoxyflurane, the onset of analgesia is relatively slow but in
spite of the low solubility it is far more potent than any of these
agents and is therefore still used for inhalational analgesia in some
settings. Maximal effect for nitrous oxide is observed in 30 to 60
seconds and wash-out effect can be obtained in three or four ex-
halations (Talebi 2009).
However, there is controversy about the use of nitrous oxide be-
cause of concerns about the safety of nitrous oxide for the sub fe-
cundability (reduction in the ability to conceive) of female mater-
nity care professionals and an increased incidence of spontaneous
abortions of the pregnant maternity care professionals (Ahlborg
1996; Axelsson 1996; Bodin 1999; Boivin 1997; Rooks 2011;
Zielhuis 1999). The underlying cause is thought to be inactivation
of methionine synthase by nitrous oxide (Sanders 2008). Cellular-
level damage can begin during a maternity-care worker’s shift in
a poorly ventilated hospital where nitrous oxide is used without
scavenging. The damage-producing process stops when themater-
nity-care worker leaves the hospital’s contaminated environment.
While she is away from the hospital, her body begins to repair any
cellular-level damage. The healing of damage that has not caused
actual pathology is referred to as restitution. If she returns to work
in a nitrous oxide-polluted environment before restitution is com-
plete, the damage-producing process resumes and restitution will
be incomplete. Over time, the damage may accumulate enough
to produce pathology (Rooks 2011).
Subfecundability in the formofmaternal absorption ofmalformed
conceptions has been found in animal studies of the reproductive
effects of very prolonged exposures to very high doses of nitrous
oxide (Sanders 2008). Nitrous oxide-induced fertility problems
occur in rats at 1000 parts per million (ppm) but not at 500 ppm
or lower. Rats are known to be particularly sensitive to damage
from nitrous oxide.
More months on average to conceive was found in a study of
dental assistants working in settings that did not use scavenging of
exhaled nitrous oxide (Rowland 1992). It was estimated that the
ambient air in which they worked was contaminated by greater
than 1000 ppm of nitrous oxide.
Current standards in the Netherlands and United States call for
limiting occupational exposure to nitrous oxide to not more than
an eight-hour time-weighted average (TWA) concentration of 25
ppm (KNOV 2009). The UK, Finland, Germany and Sweden
have set 100 ppm as their upper limits. The United States’ 25 ppm
standard was set arbitrarily during the 1970s without benefit of ac-
tual data. Nevertheless, the American Society of Anesthesiologists
(ASA), the National Institute of Occupational Safety and Health
(NIOSH) and the US Occupational Safety and Health Adminis-
tration (OSHA) all believe that this standard has been effective in
protecting American health workers. Concerns about reproduc-
tive toxicity from occupational exposure to nitrous oxide at levels
below the 25-ppm standard are not supported by the available
data, which, however, do not include findings from prospective
studies.
The risk of reproductive failure related to occupational exposure to
nitrous oxide is essentially eliminated when nitrous oxide labour
analgesia is used in well-ventilated modern hospitals and ’scaveng-
ing’ is used. The Boivin 1997 meta-analysis reached the same con-
clusion as the Rosen 2002 review: scavenging solves the problem.
Epidemiological studies based on data obtained in the pre-scav-
enging era indicated an increased risk of spontaneous abortion.
Other side effects are maternal drowsiness, nausea and vomiting
when inhaled analgesia is used too long or extensively, especially if
the rule of self-administration is violated. Renal and hepatic toxi-
city and uterine relaxation are usually not of concern at analgesic
levels of inhaled analgesia but we will include them if possible.
How the intervention might work
The precise mechanism of action of pain relief by inhaled analgesia
remains uncertain. Maze and Fuginaga hypothesised that nitrous
oxide induces the release of endogenous opioid peptides in the peri-
aqueductual grey area of the midbrain (Maze 2000). The release
of this substance in the midbrain could modulate pain stimuli
through the descending spinal cord nerve pathways.
Why it is important to do this review
It is important to do this review because all women should have
access to some form of relatively effective and safe analgesia dur-
ing labour and to provide this analgesia when women need some
form of pharmacological pain relief during labour (Rooks 2007).
Even in hospitals with full-time obstetric anaesthesia coverage, no
one may be available to place an epidural, provide another highly
effective method of labour analgesia, or provide a labour-intensive
non-pharmacological method to help the woman in pain.
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More invasive options such as epidural analgesia are associated
with significant side effects. Approximately 20% of women who
had a vaginal delivery in theUK (DOH2005; Khor 2000), 59% to
61% of women in the USA (Declercq 2007; Osterman 2011) and
10% of women in the Netherlands (PRN 2008) used an epidural
injection as pain relief in labour. The use of an epidural injection
in labour has steadily increased until the last decade in modern
highly developed countries (Anim-Somuah 2005). In some coun-
tries these figures are expected to rise even more in the coming
years, for example, in the Netherlands. The use of epidural anal-
gesia, especially within primary obstetric care, determines a higher
rate of deliveries in secondary or tertiary obstetric care hospitals,
which increases medicalisation as well as healthcare costs. In con-
clusion, it is important to have other options for pain relief during
labour in view of the side effects of the invasive options.
Inhaled pain relief during labour, especially by nitrous oxide, is
relatively easy to administer, can be started in less than a minute
and becomes effective within a minute. Since it does not affect
the physiology of labour, it can be started whenever it is needed.
However, the effectiveness and efficacy of nitrous oxide use for
management of labour pain is hard to ascertain because of the few
available data. The available data are out of date (Rosen 2002);
thus a systematic assessment of the evidence regarding the safety
and efficacy of inhaled analgesia for pain relief in labour is urgently
needed as well as for anaesthesiologists, obstetricians, hospital ad-
ministrators, midwives, nurses, women as for the general public.
This review is one in a series of Cochrane reviews examining pain
management in labour. These reviews contribute to an overview
of systematic reviews of pain management for women in labour
(Jones 2012), and share a generic protocol (Jones 2011).
O B J E C T I V E S
The main objective was to explore the efficacy and safety of in-
haled analgesia as pain relief for women in labour planning a vagi-
nal delivery. Although important to look at, the effects of occu-
pational exposure and toxic effects on reproduction for maternity
healthcare workers can only be found in large-scale epidemiologi-
cal studies. Since we only included intervention studies (see Types
of studies), we did not include these outcomes in this review.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and studies with a cross-over
design were included. We did not include quasi-RCTs.
Types of participants
Women in labour including women in high-risk groups, e.g.
preterm labour or following induction of labour.
Types of interventions
This review is one in a series of Cochrane reviews examining pain
management in labour. These reviews contribute to an overview
of systematic reviews of interventions for pain management in
labour (Jones 2012), and share a generic protocol (Jones 2011).
To avoid duplication, the different methods of pain management
have been listed in a specific order, from one to 15. Individual
reviews focusing on particular interventions include comparisons
with only the interventions above it in the list. Methods of pain
management identified in the future will be added to the end of
the list. The current list is as follows.
1. Placebo/no treatment
2. Hypnosis (Madden 2011)
3. Biofeedback (Barragán 2011)
4. Intracutaneous or subcutaneous sterile water injection
(Derry 2012)
5. Immersion in water (Cluett 2009)
6. Aromatherapy (Smith 2011a)
7. Relaxation techniques (yoga, music, audio)* (Smith 2011c)
8. Acupuncture or acupressure (Smith 2011b)
9. Manual healing methods including massage and
reflexology* (Smith 2011d)
10. TENS (transcutaneous electrical nerve stimulation)
(Dowswell 2009)
11. Inhaled analgesia (this review)
12. Opioids (Ullman 2010)
13. Non-opioid drugs (Othman 2011)
14. Local anaesthetic nerve blocks (Novikova 2011)
15. Epidural (including combined spinal epidural)
(Anim-Somuah 2011; Simmons 2007)
Accordingly, this review only includes comparisons of inhaled
analgesia with other inhaled analgesia or with: 1. placebo/no treat-
ment; 2. hypnosis; 3. biofeedback; 4. sterile water injection; 5. im-
mersion in water; 6. aromatherapy; 7. relaxation techniques (yoga,
music, audio); 8. acupuncture or acupressure; 9. manual methods
(massage, reflexology); or 10. TENS.
Interventions were any inhaled analgesia during labour such as
isoflurane, enflurane methoxyflurane and nitrous oxide. We in-
cluded any frequency or duration of administration, any dosage/
intensity, any combinations of inhaled analgesia and any timing
of labour (first, second or third stage).
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Types of outcome measures
Primary outcomes
Effects of interventions
• Pain intensity (as defined by trialists) (Likert 1932)
• Satisfaction with pain relief (as defined by trialists) collected
within 48 hours after birth
• Sense of control in labour (as defined by trialists)
• Satisfaction with childbirth experience (as defined by
trialists)
Safety of interventions
• Effect on mother/baby interaction (skin-to-skin contact of
mother and baby within the first hour of birth)
• Breastfeeding (at specified time points; within the first hour
of birth, at discharge of the hospital)
• Assisted vaginal birth
• Caesarean section
• Side effects (nausea, vomiting, drowsiness, renal and
hepatic toxicity, uterine relaxation)
• Admission to special care baby unit/neonatal intensive care
unit (as defined by trialists)
• Apgar score less than seven at five minutes
• Need for rescue analgesia (mother or baby)
• Poor infant outcomes at long-term follow-up (as defined by
trialists)
Other outcomes
• Cost (as defined by trialists)
Secondary outcomes
For the baby
• Differences in the one, two, five or 10 minute Apgar scores
• Neurological integrity scale of the newborn
For the professional
• Occupational exposure
• Toxic effects on reproduction
Search methods for identification of studies
Electronic searches
The Trials Search Co-ordinator was contacted to search the
Cochrane Pregnancy and Childbirth Group’s Trials Register (31
January 2012).
The Cochrane Pregnancy and Childbirth Group’s Trials Register
is maintained by the Trials Search Co-ordinator and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE;
3. weekly searches of EMBASE;
4. handsearches of 30 journals and the proceedings of major
conferences;
5. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Details of the search strategies for CENTRAL, MEDLINE and
EMBASE, the list of handsearched journals and conference pro-
ceedings, and the list of journals reviewed via the current aware-
ness service can be found in the ‘Specialized Register’ section
within the editorial information about the Cochrane Pregnancy
and Childbirth Group.
Trials identified through the searching activities described above
are each assigned to a review topic (or topics). The Trials Search
Co-ordinator searches the register for each review using the topic
list rather than keywords.
In addition, we searched ClinicalTrials.gov, and Current
Controlled Trials to identify ongoing trials (2 June 2012) using
the search terms detailed in Appendix 1 and Appendix 2.
Searching other resources
We searched reference lists of identified studies and handsearched
the conference proceedings from the American Society of Clinical
Anesthesia (from1990 to 2011). We also contacted content experts
and trialists.
We did not apply any language restrictions.
Data collection and analysis
Selection of studies
Two review authors independently assessed for inclusion all the
potential studies identified through the search strategy. Any dis-
agreement was resolved through discussion and, if there could not
be achieved consensus, a third author was consulted.
Data extraction and management
A formwas designed to extract data. For eligible studies, two review
authors extracted the data using the agreed form. Discrepancies
were resolved through discussion or, if required, by consulting a
third author. Data were entered into Review Manager software
(RevMan 2011) and checked for accuracy.
When information regarding any of the above was unclear, we
contacted the authors of the original reports to provide further
details.
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Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each
study using the criteria outlined in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). Any disagree-
ment was resolved by discussion or by involving a third assessor.
To assess the risk of bias, the following items were evaluated:
(1) Random sequence generation (checking for possible
selection bias)
The methods used to generate the allocation sequence were de-
scribed for each included study in sufficient detail to allow an as-
sessment of whether it should produce comparable groups.
The method were assessed as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
The methods used to conceal the allocation sequence were de-
scribed for each included study and determined whether interven-
tion allocation could have been foreseen in advance of, or during
recruitment, or changed after assignment.
The methods were assessed as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3) Blinding (checking for possible performance bias)
Themethods used, if any, to blind study participants andpersonnel
from knowledge of which intervention a participant received were
described for each included study. Studies were considered at low
risk of bias if they were blinded, or if was judged that the lack of
blinding could not have affected the results. Blinding was assessed
separately for different outcomes or classes of outcomes.
The methods were assessed as:
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel;
• low, high or unclear risk of bias for outcome assessors.
Partial blinding was used as an option because many of the admin-
istered inhaled analgesia cannot be completely blinded because of
their odour. Partial blinding was also used for self-reported effi-
cacy outcomes and when these outcomes are recorded by blinded
personnel.
(4) Incomplete outcome data (checking for possible attrition
bias through withdrawals, dropouts, protocol deviations)
The completeness of data including attrition and exclusions from
the analysis were described for each included study and for each
outcome or class of outcomes.Where attrition and exclusions were
stated it was reported, the numbers included in the analysis at each
stage (compared with the total randomised participants), reasons
for attrition or exclusionwhere reported, andwhethermissing data
were balanced across groups or were related to outcomes. Where
sufficient information was reported, or could be supplied by the
trial authors, we planned to re-include the missing data in the
analyses which we undertook. Methods were assessed as:
• low risk of bias (20% or less missing data);
• high risk of bias;
• unclear risk of bias.
(5) Selective reporting bias
How the possibility of selective outcome reporting bias was inves-
tigated and what was found was described for each included study
(Sterne 2001).
The methods were assessed as:
• low risk of bias (where it is clear that all of the study’s pre-
specified outcomes and all expected outcomes of interest to the
review have been reported);
• high risk of bias (where not all the study’s pre-specified
outcomes have been reported; one or more reported primary
outcomes were not pre-specified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
(6) Other sources of bias
Concurrent or prior use of analgesia was identified in the selected
studies because the concurrent or prior use of analgesia can give
some bias of the effects of the studied analgesia. Furthermore, any
other important concerns about other possible sources of bias was
described for each included study.
Each study was assessed whether the study was free of other prob-
lems that could put it at risk of bias:
• low risk of bias;
• high risk of bias;
• unclear risk of bias.
(7) Overall risk of bias
Explicit judgements were made about whether studies were at
high risk of bias, according to the criteria given in the Handbook
(Higgins 2011). The likely magnitude and direction of the bias
was assessed with reference to (1) to (6) above and whether it
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was considered as likely to impact on the findings. We planned
to explore the impact of the level of bias through undertaking
sensitivity analyses - see Sensitivity analysis.
The following questions were considered for assessing risk of bias
for cross-over trials.
• Was use of a cross-over design appropriate (Elbourne 2002)?
• Is it clear that the order of receiving treatments was
randomised?
• Can it be assumed that the trial was not biased from carry-
over effects? Inhaled analgesia has a relatively rapid uptake/
washout effect. We take four exhalations as the safe cut-off point
for no residual effect.
• Are unbiased data available (period effects)? Pain of uterine
contractions are not consistent over time. The pain becomes
more intense as the labour progresses until the start of delivery.
Pain of the contractions change during the delivery of the baby.
We looked for any control for labour progress at the start of the
inhaled analgesia. If the start of the analgesia was not in the same
stage of labour (in the active first stage after 3 cm dilatation) and
second stage after 10 cm dilation until birth of the baby), we
reported this risk of bias.
Measures of treatment effect
Dichotomous data
For dichotomous date, we presented results as summary risk ratio
with 95% confidence intervals and, where relevant, as risk differ-
ence and number needed to treat either to benefit or to harm.
Ordinal data
Results of ordinal data were transformed to dichotomous data for
analysis and described in the section on data analysis.
Continuous data
For continuous data, we used mean difference if outcomes were
measured in the same way between trials. The standardised mean
difference was used to combine trials that measured the same out-
come, but used different methods. Where appropriate, we used
standard inverse-variance random-effects meta-analysis to com-
bine the trials (DerSimonian 2007). The method of Hozo 2005
was used to estimate the mean and variance from the median,
range, and the size of the sample when the published reports of
the included trials only reported the median, range and the size of
trial.
Unit of analysis issues
Cross-over trials
Other unit of analysis issues
The appropriate analysis for continuous data from a two-period,
two-intervention cross-over trial, a paired T-test was planned if
neither carry-over, (aminimumof four exhalationswith room air),
nor period effects were thought to be a problem. This evaluates
the value of ‘measurement on experimental intervention (E)’ mi-
nus ‘measurement on control intervention (C)’ separately for each
participant. The mean and standard error of these different mea-
sures are the building blocks of an effect estimate and a statistical
test. The effect estimate may be included in a meta-analysis using
the generic inverse-variance method in RevMan 2011.
The simple formula of Hozo 2005 was used for small sample sizes
below 25 participants to estimate the mean using the values of
the median, low and high end of the range. The best estimator
for sample sizes which exceeds 25 is the median itself. The known
estimator Range/4 was used to estimate the standard variation for
small sample sizes between 15 and 70 participants.
Dealing with missing data
Levels of attrition were noted for included studies. We planned to
explore the impact of including studies with high levels of missing
data in the overall assessment of treatment effect by using sensi-
tivity analysis.
Analyses were carried out for all outcomes, as far as possible, on
an intention-to-treat basis, i.e. we attempted to include all partic-
ipants randomised to each group in the analyses, and all partici-
pants were analysed in the group to which they were allocated, re-
gardless of whether or not they received the allocated intervention.
The denominator for each outcome in each trial was the number
randomised minus any participants whose outcomes were known
to be missing.
Assessment of heterogeneity
Heterogeneity of treatment effects was measured between trials
using the Chi² test and the I²statistic (Deeks 2001; Higgins 2011),
which describe the percentage of total variation across trials that
is attributable to heterogeneity rather than to chance.
We assessed statistical heterogeneity in each meta-analysis using
the T², I² and Chi² statistics. We regarded heterogeneity as sub-
stantial if T² was greater than zero and either I² was greater than
30% or there was a low P value (less than 0.10) in the Chi² test
for heterogeneity.
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Assessment of reporting biases
If 10 or more studies had contributed data to meta-analysis for
any particular outcome, we planned to investigate reporting biases
(such as publication bias) using funnel plots. We would have as-
sessed possible asymmetry visually, and used formal tests for funnel
plot asymmetry. For continuous outcomes, we would have used
the test proposed by Egger 1997, and for dichotomous outcomes,
we would have used the test proposed by Harbord 2006. If asym-
metry was detected in any of these tests or was suggested by a
visual assessment, we planned to perform exploratory analyses to
investigate it.
Data synthesis
Statistical analysis were carried out using theReviewManager soft-
ware (RevMan 2011). Fixed-effectmeta-analysiswas used for com-
bining data where it was reasonable to assume that studies were
estimating the same underlying treatment effect: i.e. where trials
were examining the same intervention, and the trials’ populations
and methods were judged sufficiently similar. If there was clinical
heterogeneity sufficient to expect that the underlying treatment
effects differed between trials, or if substantial statistical hetero-
geneity was detected, random-effects meta-analysis was used to
produce an overall summary if an average treatment effect across
trials was considered clinically meaningful. Results were presented
as the average treatment effect with its 95% confidence interval,
and the estimates of T² and I² where random-effects analysis was
used.
Subgroup analysis and investigation of heterogeneity
If substantial heterogeneity was identified, for the primary out-
comes, where data were available, we planned to carry out the fol-
lowing subgroup analyses.
1. Spontaneous labour versus induced labour.
2. Primiparous versus multiparous.
3. Term versus preterm birth.
4. Continuous support in labour versus no continuous
support.
5. Mode of delivery: spontaneous vaginal, operative vaginal,
mode of delivery mixed or unclear.
6. Different methods and doses of inhaled pain relief
(inhalation agent regimen and doses).
7. Obese versus non obese women.
We also planned to look separately at results of studies in which a
50%/50% blend of N2O andO2 was self-administered by labour-
ing women and distinguish the results of those studies from the
results of studies in which:
a. the ratio of N2O to O2 was higher than 50%,
b. the ratio of N2O to O2 was lower than 50%,
c. the ratio of the gases could be changed by a professional,
d. the ratio could be changed by the labouring woman,
e. the ratio was 50%/50% but someone other than the woman
who was inhaling it administered it to her.
We planned to assess differences between subgroups by interaction
tests as described in the Handbook (Higgins 2011).
Sensitivity analysis
We planned to carry out sensitivity analyses to explore the effect
of trial quality assessed by concealment of allocation, and for the
cross-over trials as assessed by ’correct analyses for cross-over de-
sign used’, with poor quality studies with high risk of bias being
excluded from the analyses in order to assess whether this made
any difference to the overall results. We planned to carry out sen-
sitivity analyse for primary outcomes only.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of studies awaiting classification.
Results of the search
A total of 54 reports of studies were identified from the search
strategy. A total of 26 studies reporting data on 2959 women
(31 reports) were included in this review (see Characteristics of
included studies) and 21 studies (23 reports) were excluded (see
Characteristics of excluded studies).
Included studies
Study design
Eighteen of the studies were parallel design (Abboud 1981;
Abboud 1995; Arthurs 1979; Belfrage 1974; Cheng 2001;
Einarsson 1996; Enrile 1973; Ji 2002; Jones 1969; Jones 1969a;
MRC 1970; Rezaeipour 2008; Shao 2000; Stefani 1982; Swart
1991; Talebi 2009; Wang 1994; Zhang 2001) and eight cross-
over design (Arora 1992; Bergsjo 1971; Carstoniu 1994; Chia
1990; McGuinness 1984; McLeod 1985; Wee 1993; Yeo 2007).
One study had two parts (Chia 1990); the second part was a ran-
domised cross-over study. For this study, we used only the data
from the cross-over study (part II), and data were only available
for the first period (before first cross-over). Two studies had three
arms (Cheng 2001; Stefani 1982) and all the remaining studies
had two comparison arms. We did not include the third arm of
these two studies which were the control arms (no treatment). The
main comparison groups included:
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1. studies comparing one type of inhaled analgesia with
another type of inhaled analgesia (Abboud 1981; Abboud 1995;
Arora 1992; Belfrage 1974; Bergsjo 1971; Cheng 2001; Jones
1969; Jones 1969a; McGuinness 1984; McLeod 1985; Stefani
1982; Swart 1991; Wee 1993; Yeo 2007);
2. studies comparing the same types of inhaled analgesia of
different strengths (Einarsson 1996; MRC 1970);
3. studies comparing the same types of inhaled analgesia using
different delivery systems (Arthurs 1979; Enrile 1973);
4. studies comparing inhaled analgesia with placebo control/
no treatment (Carstoniu 1994; Cheng 2001; Ji 2002; Rezaeipour
2008; Shao 2000; Stefani 1982; Talebi 2009; Wang 1994; Zhang
2001);
5. and one study comparing inhaled analgesia with TENS
(Chia 1990).
Sample sizes
Sample size in the included studies ranged from 18 (Wee 1993)
to 509 patients (Talebi 2009).
Study location
The studies were conducted in the following locations: five studies
were undertaken in theUSA (Abboud 1981; Abboud 1995; Enrile
1973; Stefani 1982; Swart 1991); nine studies in the UK (Arora
1992; Arthurs 1979; Jones 1969; Jones 1969a;McGuinness 1984;
McLeod 1985; MRC 1970; Wee 1993; Yeo 2007; two studies in
Sweden (Belfrage 1974; Einarsson 1996); one study in Norway
(Bergsjo 1971); one study inCanada (Carstoniu 1994); five studies
in China (Cheng 2001; Ji 2002; Shao 2000; Wang 1994; Zhang
2001); one study in Singapore (Chia 1990); and two studies in
Iran (Rezaeipour 2008; Talebi 2009).
Participants
One study recruited only women scheduled for induced labour
(Talebi 2009) and one study only women in spontaneous labour
(Arora 1992). Three studies recruited women in both sponta-
neous and induced labour (Chia 1990; Enrile 1973; Yeo 2007)
and reporting on the onset of labour was unclear in the remain-
ing studies. Fifteen studies recruited both primiparous and multi-
parouswomen (Abboud 1981; Abboud 1995; Arora1992; Arthurs
1979; Belfrage 1974; Bergsjo 1971; Carstoniu 1994; Chia 1990;
Einarsson 1996; Enrile 1973; Jones 1969; Jones 1969a; MRC
1970; Talebi 2009; Wee 1993); four studies recruited only prim-
iparous women (Cheng 2001; Ji 2002; Rezaeipour 2008; Shao
2000); and in the remaining studies parity was not reported
(McGuinness 1984; McLeod 1985; Stefani 1982; Swart 1991;
Wang 1994; Yeo 2007; Zhang 2001). The interventions were ad-
ministered at term in five studies (Cheng 2001; Ji 2002; Shao
2000; Talebi 2009; Yeo 2007) and term of birth was unclear in
the remaining studies. The interventions were administered dur-
ing the first stage of labour (until complete dilatation and be-
fore the urge of pushing started) for 16 studies (Arora 1992;
Arthurs 1979; Bergsjo 1971; Carstoniu 1994; Cheng 2001; Chia
1990; Einarsson 1996; Ji 2002;McGuinness 1984;McLeod 1985;
Rezaeipour 2008; Shao 2000; Talebi 2009; Wee 1993; Yeo 2007;
Zhang 2001); in the second stage of labour (from the start of push-
ing until the baby is born) for six studies (Abboud 1981; Abboud
1995; Belfrage 1974; Enrile 1973; Stefani 1982; Swart 1991); in
the first and second stages of labour in three studies (Jones 1969;
Jones 1969a; MRC 1970); and stage of labour was unknown in
one study (Wang 1994). Continuous support and obesity were
not reported upon in any of the studies.
Types of intervention
Thirteen studies compared nitrous oxide 30% to 60% with a
different form of inhaled analgesia (flurane derivatives): enflu-
rane 0.25% to 1.25% (Abboud 1981; McGuinness 1984; Stefani
1982); desflurane 1.4% to 5% (Abboud 1995; Swart 1991);
methoxyflurane 0.3% to 0.8% (Bergsjo 1971; Belfrage 1974;
Jones 1969; Jones 1969a); sevoflurane 0.7% (Yeo 2007); isoflurane
0.2% to 0.75% (McLeod 1985; Cheng 2001); isoflurane 0.2%
to 0.25% and nitrous oxide 50% (Arora 1992; Wee 1993). One
study Belfrage 1974, studied nitrous oxide 70% with methoxyflu-
rane 0.3% to 0.8%. Of these studies, in five the interventions
were administered on a continuous basis (Abboud 1981; Abboud
1995; Jones 1969; Stefani 1982; Yeo 2007) and in seven on an
intermittent basis (Arora 1992; Bergsjo 1971; Cheng 2001; Jones
1969a; McGuinness 1984; McLeod 1985; Wee 1993). In one
study themethod of administrationwas not reported (Swart 1991)
and in one study it reported that the drugs were self-administered
(Belfrage 1974).
In two studies nitrous oxide 50%was compared with nitrous oxide
70% ( (Einarsson 1996; MRC 1970). In one of these studies the
intervention was administered on a intermittent basis (Einarsson
1996) and in one study the administrationwas not reported (MRC
1970). In one study intermittent nitrous oxide 50% alone was
compared with intermittent nitrous oxide 50% plus continuous
nasal supplementation of nitrous oxide 50% (Arthurs 1979). In
one study nitrous oxide 50% delivered via a Penthrane®Analgizer
was compared with nitrous oxide 50% delivered via a Cyprane®
inhaler (Enrile 1973).
Nine studies compared inhaled analgesia with placebo control/
no treatment (Carstoniu 1994; Cheng 2001; Ji 2002; Rezaeipour
2008; Shao 2000; Stefani 1982; Talebi 2009; Wang 1994; Zhang
2001). In five studies nitrous oxide 30% to 50% was compared
with oxygen or compressed air (Carstoniu 1994; Cheng 2001;
Rezaeipour 2008; Talebi 2009; Zhang 2001) and in four studies
nitrous oxide 30% to 50% was compared with no treatment (Ji
2002; Shao 2000; Stefani 1982; Wang 1994).
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One study compared nitrous oxide 50% with TENS (Chia 1990).
See Characteristics of included studies.
Outcome measures
The following primary outcomes on effects of interventions were
reported upon in the studies: pain intensity (linear analogue pain
score - mean standard deviation (SD), LAS mean SD, mean pain
intensity, visual analogue scale (VAS),WHO pain scale,Mulleetr’s
pain in labour scale) (Arora 1992; Arthurs 1979; Carstoniu 1994;
Cheng 2001; Chia 1990; Ji 2002; McGuinness 1984; McLeod
1985; MRC 1970; Rezaeipour 2008; Shao 2000; Talebi 2009;
Wang 1994; Wee 1993; Yeo 2007; Zhang 2001); satisfaction with
pain relief (within 48 hours birth, after delivery) (Abboud 1981;
Abboud 1995; Arthurs 1979; Belfrage 1974; Bergsjo 1971; Chia
1990; Jones 1969; Jones 1969a; MRC 1970; Rezaeipour 2008;
Stefani 1982; Swart 1991). No study reported upon satisfaction
with childbirth experience and no study reported upon sense of
control in labour.
The following primary outcomes on safety of interventions were
reported upon in the studies: assisted vaginal birth (Abboud
1995; Arora 1992; Belfrage 1974; Bergsjo 1971; Ji 2002; Jones
1969; McGuinness 1984; MRC 1970; Rezaeipour 2008; Stefani
1982; Yeo 2007); caesarean section (Arora 1992; Belfrage 1974;
Bergsjo 1971; Enrile 1973; Ji 2002; McGuinness 1984; MRC
1970; Rezaeipour 2008; Yeo 2007; Zhang 2001); side effects
(vomiting, amnesia, dizziness, nausea, hypoxaemia, post-partum
haemorrhage, anoxia newborn, neonatal asphyxia) (Abboud 1981;
Abboud 1995; Arora1992; Arthurs 1979; Bergsjo 1971; Einarsson
1996; Enrile 1973; Ji 2002; Jones 1969; Jones 1969a;McGuinness
1984; McLeod 1985; MRC 1970; Shao 2000; Swart 1991; Talebi
2009; Wang 1994; Wee 1993; Yeo 2007; Zhang 2001); admis-
sion to special care baby unit/neonatal intensive care (Chia 1990);
Apgar score (Abboud 1981; Arthurs 1979; Belfrage 1974; Cheng
2001; Chia 1990; Enrile 1973; Jones 1969; Rezaeipour 2008;
Stefani 1982; Talebi 2009; Wang 1994; Wee 1993; Ji 2002). No
studies reported upon the need of rescue analgesia or upon ef-
fect on mother/baby interaction, breastfeeding or poor infant out-
comes at long-term follow-up.
The only secondary outcome reported upon in the studies was
neurological integrity scale of the newborn (Abboud 1995; Cheng
2001; Stefani 1982; Swart 1991). No study reported upon out-
comes of the professionals attending the birth.
Excluded studies
We excluded 21 studies: see Characteristics of excluded studies.
Six studies were not randomised controlled trials (Arozenius
1980; Chessor 2005; Cosmi 1969; Davies 1975; McAneny 1963;
Roberts 1957) and five studies used quasi methods of randomisa-
tion (Arthurs 1981;Davies 1974;Major 1967; Rosen 1969; Rosen
1972). In two studies the studies were investigating the effect of
general anaesthesia in women undergoing caesarean section and
not during childbirth (Crawford 1975; Krantz 1974) and in three
studies the comparison interventions are no longer used in prac-
tice (trichloroethylene; cyclopropane) (Major 1966; Phillips 1971;
Shnider 1963). In five studies the comparison interventions were
opioids, epidural or other multidrug interventions and therefore
did not meet the inclusion criteria of this review according to the
pain management hierarchy (Clark 1979; Creasser 1974; Howell
2001; Robinson 1980; Volmanen 2005).
Risk of bias in included studies
See Figure 1; Figure 2, for further details regarding ’Risk of bias’
assessment.
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Figure 1. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 2. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Random sequence generation
Seven of the trials (27%) were rated as low risk of bias for sequence
generation (Abboud 1995; Arora 1992; Bergsjo 1971; Carstoniu
1994; Enrile 1973; Shao 2000; Talebi 2009) and in the remaining
trials the method of sequence generation was unclear (Abboud
1981; Arthurs 1979; Belfrage 1974; Cheng 2001; Chia 1990;
Einarsson 1996; Ji 2002; Jones 1969; Jones 1969a; McGuinness
1984;McLeod 1985;MRC 1970; Rezaeipour 2008; Stefani 1982;
Swart 1991; Wang 1994; Wee 1993; Yeo 2007; Zhang 2001).
Allocation concealment
In only three studies (11%) was allocation concealment rated as
low risk of bias (Bergsjo 1971; Carstoniu 1994; Chia 1990) and
unclear in the remaining trials (Abboud 1981; Abboud 1995;
Arora 1992; Arthurs 1979; Belfrage 1974; Cheng 2001; Einarsson
1996; Enrile 1973; Ji 2002; Jones 1969; Jones 1969a;McGuinness
1984; McLeod 1985; MRC 1970; Rezaeipour 2008; Shao 2000;
Stefani 1982; Swart 1991; Talebi 2009; Wang 1994; Wee 1993;
Yeo 2007; Zhang 2001).
Blinding
Blinding of participants and personnel was at low risk of bias three
studies (11%) (Abboud 1981; Abboud 1995; Swart 1991), high
risk in four studies (Belfrage 1974; Bergsjo 1971; Enrile 1973; Yeo
2007) and unclear in the remaining studies (Arora 1992; Arthurs
1979; Carstoniu 1994; Cheng 2001; Chia 1990; Einarsson 1996;
Ji 2002; Jones 1969; Jones 1969a; McGuinness 1984; McLeod
1985; MRC 1970; Rezaeipour 2008; Shao 2000; Stefani 1982;
Swart 1991; Talebi 2009; Wang 1994; Wee 1993; Zhang 2001).
Blinding of outcome assessment was at low risk of bias in three
studies (Stefani 1982; Rezaeipour 2008; Talebi 2009) (9%), high
risk in four studies (Belfrage 1974; Bergsjo 1971; Enrile 1973;
Yeo 2007) and unclear in the remaining studies (Abboud 1981;
Abboud 1995; Arora 1992; Arthurs 1979; Carstoniu 1994; Cheng
2001; Chia 1990; Einarsson 1996; Ji 2002; Jones 1969; Jones
1969a;McGuinness 1984;McLeod1985;MRC1970; Shao2000;
Swart 1991; Wang 1994; Wee 1993; Zhang 2001).
Incomplete outcome data
Thirteen (50%) of the trials were rated as low risk of bias for
incomplete outcome data (Abboud 1981; Abboud 1995; Arora
1992; Bergsjo 1971; Einarsson 1996; Jones 1969a; McLeod 1985
McGuinness 1984; Rezaeipour 2008; Stefani 1982; Talebi 2009;
Wee 1993; Zhang 2001) and at high risk of bias in four (Carstoniu
1994; Jones 1969;MRC1970; Yeo2007). In the remaining studies
risk of bias for incomplete outcome data was unclear (Arthurs
1979; Belfrage 1974; Cheng 2001; Chia 1990; Enrile 1973; Ji
2002; Shao 2000; Swart 1991; Wang 1994).
Selective outcome reporting
Sixteen (62%) of the trials were rated as low risk of bias for selective
outcome reporting (Abboud 1981; Abboud 1995; Bergsjo 1971;
Carstoniu 1994; Chia 1990; Einarsson 1996; Ji 2002; Jones 1969;
Jones 1969a; McGuinness 1984; McLeod 1985; MRC 1970;
Stefani 1982; Talebi 2009; Wee 1993; Yeo 2007) and at high risk
of bias in five (Arora 1992; Arthurs 1979; Cheng 2001; Enrile
1973; Zhang 2001). In the remaining studies risk of bias for was
unclear (Belfrage 1974; Rezaeipour 2008; Shao 2000; Swart 1991;
Wang 1994).
Other bias
Six (23%) of the trials were rated as being at low risk of bias for
’other bias’ (Carstoniu 1994; Chia 1990; Jones 1969a; McLeod
1985; Stefani 1982; Yeo 2007) and at high risk of bias in three
studies (baseline imbalance including no information of prior
or concurrent use of other analgesia; delivery systems for inter-
ventions not comparable) (Enrile 1973; Ji 2002; Talebi 2009).
In the remaining 17 studies (65%), risk of bias for was unclear
(Abboud 1981; Abboud 1995; Arora 1992; Arthurs 1979; Belfrage
1974; Bergsjo 1971; Cheng 2001; Einarsson 1996; Jones 1969;
McGuinness 1984; MRC 1970; Rezaeipour 2008; Shao 2000;
Swart 1991; Wang 1994; Wee 1993; Zhang 2001).
Cross-over trials
All eight cross-over trials randomised the order of interventions.
Three studies (Arora 1992; Bergsjo 1971; Carstoniu 1994) were at
low risk of bias for method of randomisation due to well described
randomisation and five studies (Chia 1990; McGuinness 1984;
McLeod 1985; Wee 1993; Yeo 2007) are with unclear risk of bias
due to unclear description of randomisation.
In one study (Chia 1990), the study was divided into two parts:
the first part was not randomised and the second part was a ran-
domised cross-over trial. The data from the first period of the
cross-over trial were used and analysed as a parallel trial. One
study (McLeod 1985) had an adequate wash-out period of two
contractions. Two studies (Arora 1992; Bergsjo 1971) used one
contraction with air breathing between the two different agents,
long enough to ensure an adequate four wash-out exhalation pe-
riod. Three cross-over trials (Carstoniu 1994; McGuinness 1984;
Wee 1993) reported no information on a wash-out period, but
the inhaled analgesia were self-administered during contractions.
This means that an adequate wash-out period of a minimum of
four exhalations was met in the pause between two contractions.
In the study by Yeo 2007, the wash-out period is unclear, due to
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the fact that participants were given the option, if they wished, to
omit the wash-out period of breathing room air over one contrac-
tion between the different agents. No information was given on
how many participants took this option. However, the minimum
wash-out period of four exhalations was probably met, due to the
method of self-administering the inhaled analgesia in this study.
It is very likely that the women will have rested for a moment
between the contractions, probably without inhaling the agent.
The double cross-over design of Yeo 2007 and Wee 1993 in-
cluded compensation for the progressive nature of labour and
therefore are evaluated as a good and appropriate design. The five
cross-over studies of Arora 1992; Bergsjo 1971; Carstoniu 1994;
McGuinness 1984 and McLeod 1985 were all single cross-over
studies but are believed to have an appropriate design due to the
short duration of the intervention and comparison period (from
three to five contractions in active part of labour). In these single
cross-over studies progression of labour is not thought to be of
influence.
All the eight cross-over studies (Arora 1992; Bergsjo 1971;
Carstoniu 1994; Chia 1990; McGuinness 1984; McLeod 1985;
Wee 1993; Yeo 2007) were carried out during the first stage in ac-
tive (established) labour until 10 cm dilation or when women felt
the urge to push (end of the first stage and start second stage). We
were only able to obtain individual patient data from one study
(Wee 1993) which appeared to be incomplete. We decided to use
only the data of the first part of this study as a parallel group trial.
The appropriate data necessary to include from a paired analysis
were only available for the incidence of side effects from one study
(Yeo 2007). However, because of concern over carry-over effects,
outcome data for side effects for cross-over studies were not in-
cluded in any analyses.
In two studies (McGuinness 1984; McLeod 1985), the Wilcoxon
paired T-sample test was performed for the effect estimate of pain
relief and pain intensity. No data were available on individual
patients for the meta-analysis. It was not possible to extract the
paired data from these two studies (McGuinness 1984; McLeod
1985). In five cross-over studies, continuous data on pain intensity
or pain relief were reported (Arora 1992; McGuinness 1984;
McLeod 1985; Wee 1993; Yeo 2007), and data were represented
as mean/SD (Arora 1992) or median/range (McGuinness 1984,
Yeo 2007) or mean/range (McLeod 1985) or individual VAS after
one hour (Wee 1993) before the first cross-over. These data were
available only for the whole experimental and comparison group
periods separately and analysed as if the trials were a parallel group
trial of experimental verus comparison. This statistical method is
of high risk due to the conservative way that studies are under
weighted, rather than over weighted (Elbourne 2002).
Correct analysis for cross-over design used
Five of the cross-over studies (63%) were rated as high risk of
bias for ’correct analysis for cross-over design used’ (Arora 1992;
McGuinness 1984; McLeod 1985; Wee 1993; Yeo 2007).
Effects of interventions
We included data from 23 trials (2599 women) using different
modalities of inhaled analgesia for pain management in labour for
our meta-analyses. In three studies (Carstoniu 1994; Shao 2000;
Wang 1994), data could not be included in the meta-analyses. In
the Carstoniu 1994 study, data were not reported in a form that
could be included in the meta-analyses (only in figures). In Shao
2000 and Wang 1994, the data are limited in the translation of
the papers, which were not published in English. We included
only the data of the first period before the first cross over for the
Wee 1993 cross-over trial, because the data from the second and
third periods were incomplete. Wee 1993 was analysed as if the
trial was a parallel group study design. We used the data from the
whole of each intervention period for the following four cross-
over studies Arora 1992, McGuinness 1984, McLeod 1985 and
Yeo 2007 and analysed the data as if it were from a parallel study.
We did not combine results from parallel and cross-over studies
in the analyses, but analysed these separately.
1) Inhaled analgesia nitrous oxide versus a different
type of inhaled analgesia (flurane derivatives)
Primary outcomes
Effects of interventions
1.1) Pain intensity
Pain intensity wasmeasured using aVAS from0 to 100mm,where
0 corresponds to no pain at all and 100 corresponds to the worst
pain. Measurements were taken during the first stage of labour
(until pushing occurred) and the data were reported as contin-
uous data. Three studies with 123 measurements of 70 women
(Analysis 1.1) reported on this outcome. The three studies were all
cross-over trials with an adequate wash-out period of minimum
of four exhalations. No period effect was present, because the tri-
als started in active labour with regular contractions to 4 cm di-
latation, during a period of three to five consecutive contractions
(McGuinness 1984; McLeod 1985) to one hour (Wee 1993). We
could not analyse the outcomes for the first period, before the first
cross-over took place, because only the Wee 1993 study gave the
individual patient data after correspondence with the trialist. The
other two studies (McGuinness 1984; McLeod 1985) did not re-
port on this first period and we did not succeed in contacting the
trialist for the original data. The data for a paired analysis were not
available.We decided to analyse the studies conservatively, as if the
trials had a parallel group design, thereby under-estimating rather
than over-estimating any differences between interventions.
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There was substantial heterogeneity indicated by the I² statistics
(Tau² =32.85, I² = 42%) and thereforewe applied a random-effects
model. The flurane derivatives group reported a lower intensity
of pain compared with the nitrous oxide group (average mean
difference (MD) 14.39, 95% confidence interval (CI) 4.41 to
24.37), Analysis 1.1.
1.2) Pain relief
Pain relief was measured using a VAS from 0 to 100mm in the first
stage of labour where 100 means themost relief. The highest score
is the most positive contrary to ’pain intensity’ in which the higher
scores is more negative. Continuous data on pain relief of women
in the first stage of labour were reported from two cross-over trials
with 158 measurements of 70 women (Analysis 1.2). The two
studies were both cross-over trials with no data available to use
for paired analysis. We also decided to analyse these studies in the
conservative way. There was substantial heterogeneity indicated by
the I² statistics (Tau² = 24.42, I² = 40%) and therefore, we applied
a random-effects model. The Flurane derivatives group reported
better pain relief compared with the nitrous oxide group (average
MD -16.32, 95% CI -26.85 to -5.79).
1.3) Satisfaction with pain relief
Satisfaction with pain relief scores assesses to what extent women
are satisfied with the form of pain relief, rather than scoring the
extent of pain itself. Satisfaction of pain relief was measured during
the first and second stages of labour as considerable to complete
and reported as dichotomous data. A considerable to complete
score means the women were satisfied with the amount of pain
relief. It was reported in two studies with 98 women (Analysis
1.3). There was no difference in satisfaction with pain relief for
women receiving methoxyflurane (continuous (mean 0.22%) or
intermittent (0.35%)) compared with women receiving nitrous
oxide (continuous (41.2%) or intermittent (50%)) (risk ratio (RR)
0.97, 95% CI 0.80 to 1.18).
1.4) Satisfaction with pain relief
This was measured during the second stage of labour as good to ex-
cellent and was reported in four studies with 323 women (Analysis
1.4). A good to excellent score means the women were satisfied
with the amount of pain relief.There was no difference in satis-
faction with pain relief for women receiving nitrous oxide (self-
administered, intermittent or continuous) compared with women
receiving an agent from the flurane derivatives group (self-admin-
istered or continuous) (RR 0.89, 95% CI 0.78 to 1.01).
No trials reported on the following outcomes: sense of control in
labour and satisfaction with childbirth experience.
Safety of interventions
1.5) Assisted vaginal birth (vacuum extraction or forceps)
Numbers of assisted vaginal births are given infive studies (Abboud
1981; Abboud 1995; Belfrage 1974; Jones 1969; Stefani 1982)
with 371women (Analysis 1.5). There was substantial heterogene-
ity indicated by the I² statistics (I² = 34%, Tau² = 0.10) and there-
fore, we applied a random-effects model. There were no differ-
ences in assisted vaginal births between women receiving nitrous
oxide and those receiving a flurane derivative (average RR 0.71,
95% CI 0.44 to 1.15). All the trials were conducted in the second
stage of labour.
1.6) Caesarean section
Caesarean section was reported in one trial (Belfrage 1974) with
98 women (Analysis 1.6). There were no caesarean sections in
either group.
1.7) Amnesia
Amnesia in women, which was scored as a dichotomous outcome,
was reported in three studies with 245 women (Analysis 1.7).
There was significant heterogeneity indicated by the I² statistics
(I² = 74%, Tau² = 2.76) and therefore we applied a random-ef-
fects model. There was no difference in amnesia between groups
with these three trials (average RR 0.26, 95% CI 0.03 to 2.38).
We repeated the analysis excluding Abboud 1981 due to using a
different flurane derivative, (enflurane instead of desflurane). In
the remaining studies of Abboud 1995; Swart 1991, both using
desflurane 0.1 to 4.5%, I² = 0%, we applied a fixed-effects model.
There was less amnesia in nitrous oxide group compared to des-
flurane group (RR 0.09, 95% CI 0.02 to 0.48).
1.8) Drowsiness
Drowsiness in women, which was scored with VAS, 0 to 100 mm,
was reported in one study with 18 women (Analysis 1.8). There
was no difference in drowsiness between the nitrous oxide group
and the Isoflurane group (MD -11.64, 95% CI -16.04 to 39.32).
1.9) Nausea
Nausea in women, which was scored as a dichotomous outcome,
was reported in two trials with 98 women (Analysis 1.9). The ni-
trous oxide group reported more nausea compared with the flu-
rane derivatives group (RR 6.60, 95% CI 1.85 to 23.52).
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1.10) Vomiting
Vomiting inwomen, whichwas scored as a dichotomous outcome,
was reported in three trials with 203women (Analysis 1.10). There
was no difference in vomiting between nitrous oxide group com-
pared with the flurane derivatives group (RR 2.02, 95% CI 0.75
to 5.46).
1.11) Blood loss
Blood loss in the third stage of labour, which was scored as a
continuous outcome in ml, was reported in two studies with 185
women (Analysis 1.11). Data from Abboud 1995 were not re-
ported in a form that could be included in themeta-analysis (mean
without standard error). There was no difference in blood loss be-
tween groups (MD 6.0 ml, 95% CI -32.91 to 44.91, one trial,
105 women).
1.12) Apgar score less than seven at five minutes
Apgar scores of less than or equal to seven or less than seven at five
minutes were reported in five trials with 373 women with single
births (Analysis 1.12). There were no differences between groups,
although each study used slightly different parameters. Abboud
1981; Belfrage 1974; Cheng 2001 and Stefani 1982 reported the
percentages of babies in each group with Apgar scores less than
eight at five minutes and Abboud 1995 reported the percentage
of babies with Apgar scores less than seven at five minutes. Two
babies were reported with an Apgar score of less than eight at five
minutes postpartum in the Flurane derivatives group in one study
(RR 0.22, 95% CI 0.01 to 4.47) and none in the nitrous oxide
group. There were no low Apgar scores in the other five trials.
No trials reported on effect on mother/baby interaction or skin
to skin contact of mother and baby within the first hour of birth;
breastfeeding at specified time points, i.e. within the first hour of
birth and at discharge of the hospital; admission to special care
baby unit or neonatal intensive care unit; need for rescue analgesia
for mother or baby; poor infant outcomes at long-term follow-up.
Other outcomes
No trials reported on any cost outcome.
Secondary outcomes
For the infant
1.13) Neurologic Adaptive Capacity Scores (NACS) lower
than 35 at two hours after delivery
NACS were reported in three studies with 170 babies (Analysis
1.13). There were no differences in NACS between groups (RR
1.45, 95% CI 0.91 to 2.33).
No trials reported on differences in the one, two, five or 10 minute
Apgar scores of the baby.
For the professional
No trials reported on differences in occupational exposure and
toxic effects on reproduction for the professional.
2) Inhaled analgesia (same type) of one strength
versus a different strength
Primary outcomes
Effects of interventions
2.1) Satisfaction with pain relief
Satisfaction with pain relief during the first stage of labour was
scored on an ordinal scale as good to complete and reported in one
study with 501 women comparing nitrous oxide 50%with nitrous
oxide 70% (Analysis 2.1). There was no difference in satisfaction
with pain relief as good to complete between groups (RR 1.05,
95% CI 0.94 to 1.17).
2.2) Satisfaction with pain relief
Satisfactionwith pain relief in the second stage of labourwas scored
on an ordinal scale as good to complete in one study with 501
women (Analysis 2.2). This study compared nitrous oxide 50%
with nitrous oxide 70%. There was no difference in satisfaction
with pain relief as good to complete between groups (RR 0.97,
95% CI 0.87 to 1.08).
No trials reported on effect on mother/baby interaction or skin-
to-skin contact of mother and baby within the first hour of birth;
breastfeeding at specified time points, i.e. within the first hour of
birth and at discharge of the hospital; admission to special care
baby unit or neonatal intensive care unit; need for rescue analgesia
for mother or baby; poor infant outcomes at long-term follow-up;
sense of control in labour; satisfaction with childbirth experience.
Other outcomes
No trials reported on any cost outcome.
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Safety of interventions
2.3) Caesarean section
Caesarean section was reported in one study with 501 women
comparing nitrous oxide 50% with nitrous oxide 70% (Analysis
2.3). There was no difference in caesarean section rate between
groups (RR 0.31, 95% CI 0.06 to 1.53).
2.4) Assisted vaginal birth
Assisted vaginal birth was reported in one study with 501 women
comparing nitrous oxide 50% with nitrous oxide 70% (Analysis
2.4). There was no difference in assisted vaginal birth rate between
groups (RR 0.83, 95% CI 0.61 to 1.14).
2.5) Vomiting
Vomiting, scored as a dichotomous outcome, was reported in one
study with 501 women comparing nitrous oxide 50%with nitrous
oxide 70% (Analysis 2.5). There was no difference in vomiting
between groups (RR 1.29, 95% CI 0.86 to 1.94).
2.6) Postpartum haemorrhage
Postpartumhaemorrhage, whichwas scored as a dichotomous out-
come and not defined (probably more than 500 mL blood loss
due to being an English report and international standards), was
reported in one study with 501 women comparing nitrous oxide
50% with nitrous oxide 70% (Analysis 2.6). There was no differ-
ence in postpartum haemorrhage between groups (RR 0.80, 95%
CI 0.38 to 1.70).
2.7) Hypoxaemia in mother
Hypoxia of the mother, which was scored as a dichotomous out-
come, was reported in one study of 24 women comparing nitrous
oxide 50% with nitrous oxide 70% (Analysis 2.7). There was no
difference in hypoxia of the mother between groups (RR 1.00,
95% CI 0.07 to 14.21).
Secondary outcomes
No trials reported on the following outcomes: differences in the
one, two, five or 10 minute Apgar scores, neurological integrity
scale of the newborn, occupational exposure and toxic effects on
reproduction for the professional.
3) Inhaled analgesia using one type of delivery system
versus a different system
Primary outcomes
Effects of interventions
3.1) Satisfaction with pain relief
Satisfaction with pain relief during the first stage of labour was
scored on an ordinal scale as considerable to complete in one study
with 42 women. The study compared nitrous oxide 50% with
nasal supplement of nitrous oxide 50% versus nitrous oxide 50%
and no supplement (Analysis 3.1). There was no difference in
satisfaction with the pain relief between groups (RR 1.18, 95%
CI 0.94 to 1.48).
Other outcomes
No trials reported on any cost outcome.
Safety of interventions
3.2) Caesarean section
Caesarean section was reported in one study with 26 women (
Analysis 3.2). The study comparedmethoxyflurane delivered from
a Penthrane® analgizer versus methoxyflurane delivered from a
Cyprane® inhaler.There was no difference in caesarean section
rate between groups (RR 2.60, 95% CI 0.12 to 58.48).
3.3) Vomiting (N2O/N2O with nasal supplement)
Vomiting, which was scored as a dichotomous outcome, was re-
ported in one study with 49 woman (Analysis 3.3). The study
compared nitrous oxide 50% with continuous nasal supplemen-
tation of nitrous oxide 50% versus nitrous oxide 50% with no
inhalation. There was no difference in vomiting between groups
(RR 1.76, 95% CI 0.77 to 4.00).
3.4) Vomiting (Penthrane® versus Cyprane®)
Vomiting, which was scored as a dichotomous outcome, was re-
ported in one study with 26 women (Analysis 3.4). The study
compared methoxyflurane delivered from a Penthrane® analgizer
versus methoxyflurane delivered from a Cyprane® inhaler. There
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was no difference in vomiting between groups (RR not estimable).
There was no vomiting in either group.
3.5) Postpartum haemorrhage
Postpartum haemorrhage, which was scored as a dichotomous
outcome probably scored above 500 mL blood loss due to the
United States report and international standards, was reported
in one study with 26 women (Analysis 3.5). The study com-
pared methoxyflurane delivered from a Penthrane® analgizer ver-
sus methoxyflurane delivered from a Cyprane® inhaler. There was
no difference in postpartum haemorrhage between groups (RR
0.29, 95% CI 0.01 to 6.50).
3.6) Mild pre-eclampsia
Mild pre-eclampsia was reported in one study with 26 women (
Analysis 3.6). The study comparedmethoxyflurane delivered from
a Penthrane® analgizer versus methoxyflurane delivered from a
Cyprane® inhaler. There was no difference in mild pre-eclampsia
between groups (RR 0.86, 95% CI 0.06 to 12.28).
3.7) Apgar score less than seven at five minutes (continuous
data)
Apgar score at five minutes was reported in one study with 26
women with 14 observations in Analgizer group and 10 obser-
vations in Cyprane group. There were two missing observations
in this Cyprane group (Analysis 3.7).The missing data could
not be obtained from the original investigators.The study com-
pared methoxyflurane delivered from a Penthrane® analgizer ver-
sus methoxyflurane delivered from a Cyprane® inhaler. There was
no difference in Apgar scores between groups (MD 0.00, 95% CI
-0.37 to 0.37). The two missing data of AS are assumed to be ’not
missing at random’. At first we imputed these two missing data
and assumed them to be poor outcomes with Apgars scores of six
at five minutes. There was still no difference apparent (MD 0.50,
95% CI -0.30 to 1.30). Secondly we imputed these data as means
of both nine for the missing data in the Cyprane group (MD 0.00
95% CI -0.35 to 0.35), and still no difference in Apgar Scores was
found between groups.
3.8) Apgar score less than seven at five minutes (continuous
data) N2O/N2O with nasal supplementation
Apgar score at five minutes was reported in one study with 49
women (Analysis 3.8). The study compared nitrous oxide 50%
versus nitrous oxide 50% with nasal supplementation of nitrous
oxide 50%.There was no difference of Apgar score between groups
(MD -0.30, 95% CI -0.81 to 0.21).
Secondary outcomes
No trials reported on the following outcomes: differences in the
one, two, five or 10 minute Apgar scores, neurological integrity
scale of the newborn, occupational exposure and toxic effects on
reproduction for the professional.
4) Inhaled analgesia versus placebo control/no
treatment
Primary outcomes
Effects of interventions
4.1) Pain intensity (dichotomous)
Pain intensity during the first stage of labour reported as clear
or severe to intense or extreme was reported in two studies with
310 women (Analysis 4.1). There was substantial heterogeneity
indicated by the I² statistics (I² = 51%, Tau² = 1.08) and therefore
we applied a random-effects model. The inhaled analgesia group
of nitrous oxide 30% to 50% reported less pain compared with
the control (O2 100%) or no treatment group (average RR 0.06,
95% CI 0.01 to 0.34).
4.2) Pain intensity (continuous)
Pain intensity in the first stage of labour reported with the VAS
(VAS, 0-10) after one hour was reported in one study with 509
women (Analysis 4.2). The study compared nitrous oxide 50%
versus oxide 50%. The nitrous oxide group reported less pain
compared with the oxide group (MD -3.50, 95% CI -3.75 to -
3.25).
Other outcomes
No trial reported on cost outcomes.
Safety of interventions
4.3) Assisted vaginal birth
Assisted vaginal birth was reported in one study with 200 women
(Analysis 4.3). The study compared nitrous oxide 50% versus
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no analgesic. There was no difference in assisted vaginal births
between groups (RR 1.50, 95% CI 0.44 to 5.15).
4.4) Caesarean section
Caesarean section was reported in three studies with 465 women
(Analysis 4.4). The studies compared nitrous oxide 30% to 50%
versus no analgesia or oxygen 100%. There was no difference in
caesarean section rate between groups (RR 1.20, 95% CI 0.75 to
1.91).
4.5) Vomiting
Vomiting, which was scored as a dichotomous outcome, was re-
ported in two studies with 619 women (Analysis 4.5). The studies
compared nitrous oxide 30% to 50% versus oxide 50% to 100%.
The nitrous oxide group reported more vomiting compared with
the oxide group (RR 9.05, 95% CI 1.18 to 69.32).
4.6 - 4.7 - 4.8) Nausea, dizziness and drowsiness
Dichotomous data on nausea, dizziness and drowsiness were re-
ported in one study with 509 women (Analysis 4.6, Analysis 4.7,
Analysis 4.8).The study compared nitrous oxide 50% versus oxy-
gen 50%. The nitrous oxide group reported significantly more
nausea (RR43.10, 95%CI 2.63 to 706.74), dizziness (RR 113.98,
95% CI 7.09 to 1833.69) and drowsiness (RR 77.59, 95% CI
4.80 to 1254.96) compared with the oxygen group.
4.9) Neonatal asphyxia
Neonatal asphyxia, which was scored as a dichotomous outcome
without definition, was reported in one study with 110 women
(Analysis 4.9). The study compared nitrous oxide 30% to 50%
versus oxygen 100%. There was no difference between groups (RR
1.11, 95% CI 0.26 to 4.73).
4.10) Apgar score the same or less than seven at five minutes
Apgar scores lower than eight at five minutes postpartum were
reported in one study with 200 women (Analysis 4.10). The study
compared nitrous oxide 50% versus no analgesic use. There were
4/100 low Apgar scores in the nitrous oxide group and none in
the control group, with no difference between groups (RR 9.00,
95% CI 0.49 to 165.00).
4.11) Apgar score (continuous data at five minutes)
Apgar scores (continuous data) were reported in one study with
509 women (Analysis 4.11). The study compared nitrous oxide
50% versus oxygen 50%. There was no difference between groups
(MD 0.00, 95% CI -0.13 to 0.13).
Secondary outcomes
No trials reported on the following outcomes: differences in the
one, two, five or 10 minute Apgar scores, neurological integrity
scale of the newborn, occupational exposure and toxic effects on
reproduction for the professional.
5) Inhaled analgesia versus TENS
Primary outcomes
Effects of interventions
5.1) Satisfaction with pain relief
Satisfaction with pain relief in the first stage of labour was scored
on an ordinal scale as partial to complete and was reported in one
study with 20 women (Analysis 5.1). The study compared nitrous
oxide 50% versus TENS. There was no difference between groups
(RR 0.56, 95% CI 0.29 to 1.07).
5.2) Pain intensity first stage of labour, ordinal moderate to
severe
Pain intensity in the first stage of labour was scored on an ordinal
scale as moderate to severe was reported in one study with 19
women (Analysis 5.2). The study compared nitrous oxide 50%
versus TENS. There was no difference between groups (RR 1.10,
95% CI 0.84 to 1.45).
Other outcomes
No trial reported on cost outcomes.
Secondary outcomes
No trials reported on the following outcomes: differences in the
one, two, five or 10 minute Apgar scores, neurological integrity
scale of the newborn, occupational exposure and toxic effects on
reproduction for the professional.
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Assessment of reporting biases
Due to the fact that there were not 10 or more studies (as we
described in our protocol) in any meta-analysis, assessment of
reporting biases (such as publication bias) was not appropriate.
Subgroup analysis and investigation of heterogeneity
Planned subgroup analyseswere not carried out because a complete
breakdown of the separate subgroup categories was not provided
in the published articles.
Sensitivity analysis
Planned sensitivity analysis for studies of poor quality, as assessed
by ’high risk of concealment of allocation’ were not conducted
because all studies were assessed as either low or unclear risk of
bias for this item.
We could not conduct planned sensitivity analysis for the cross-
over trials of poor quality, as assessed by high risk of bias of ’correct
analysis for cross-over design used’ because all studies were assessed
as high risk of bias for this item.
D I S C U S S I O N
Summary of main results
This review demonstrated that women in labour using flurane
derivatives as inhaled analgesia during the first stage of labour re-
ported better pain relief and less intense pain than nitrous oxide,
and reported less nausea. However, these findings should be con-
sidered with caution because of the way we analysed the data from
the cross-over studies. The cross-over studies did not provide data
in the form of a correct paired analysis. We were therefore only
able to include data in meta-analyses from the whole of each inter-
vention period for four of the studies (Arora 1992; McGuinness
1984; McLeod 1985; Yeo 2007) and from the first period before
cross-over for one study (Wee 1993). We therefore analysed the
data from the cross-over studies as if they were parallel group tri-
als. The results for flurane derivatives are based on data from 13
studies. However, there was a high level of heterogeneity for the
analyses of pain relief and for intensity of pain, and so these results
should also be examined with caution. Although we reported on
drowsiness with regards to safety of the intervention, we also know
that drowsiness is often seen as a beneficial side effect.
This review also demonstrated that women reported less pain
intensity for intermittent (self-administered) nitrous oxide 50%
when compared to no analgesia, during the first stage of labour
and less intense pain intensity for intermittent (self-administered)
nitrous oxide 50% when compared to oxygen 50% in the first
stage of labour. More vomiting was observed with intermittent
(self-administered) nitrous oxide 30% to 50% when compared to
oxygen 50% to 100%, and more nausea, dizziness and drowsiness
was observed with intermittent (self-administered) nitrous oxide
50% when compared to oxygen 50%. These results are based on
data from three studies. There was a high level of heterogeneity
for the analysis of pain intensity for nitrous oxide 50% versus no
analgesia. Therefore, this result should also be examined with cau-
tion.
There were no significant differences found for any of the out-
comes in the studies comparing one strength versus a different
strength of inhaled analgesia, in studies comparing different de-
livery systems or in the study comparing inhaled analgesia with
TENS.
All these conclusions need to be considered in the context of small
sample sizes (range 27 to 320); only three trials achieved a sample
size of more than 200; blinding to the intervention was hardly
possible in many studies, due to the smell of the agent; and many
outcomes were only considered in one or two trials in specific
groups of comparison. These factors limit the interpretation of the
results.
A sensitivity analysis was planned in order to explore the impact
of excluding the cross-over trials, assessed as being at a high risk
of bias for the item ’correct analysis for cross-over design used’,
to see if this would make a difference to the overall results. We
could not perform this analysis for ’pain intensity’ or ’pain relief ’
because these analyses only included cross-over trials and all of
these were at high risk of bias for ’correct analysis for cross-over
design used.’ The majority of cross-over trials were analysed as
if they were parallel group trials, using the data from the overall
outcome of the intervention versus the overall outcome of the
comparison agent. This statistical method is at high risk of bias
due to the conservative way, that studies are under weighted rather
than over weighted (Elbourne 2002).
Overall completeness and applicability of
evidence
The completeness and applicability of the evidence is limited from
the 26 included trials, with no trial at a low risk of bias on all
domains. A weakness of a number of the trials is the inclusion of
relatively few outcomes and for all trials omission of clinical safety
outcomes for the professional. Although almost all participants
across the included trials were considered at low risk of complica-
tions because of the following exclusion criteria within the indi-
vidual trials: major uterine abnormalities, multiple gestation, car-
diovascular or respiratory instability and acute or chronic obstet-
ric pathologies such as pre-eclampsia and mostly participants in
spontaneous labour, one trial (Chia 1990) explicitly included nul-
liparouswith induced labour in the second part of the study, which
was randomised. This trial (Chia 1990) is the only trial in the
comparison group ’Inhaled analgesia versus TENS’ and therefore,
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it was not possible to assess for subgroup differences. There were
also no significant differences found between inhaled analgesia of
nitrous oxide 50% and TENS for the two outcomes analysed. In
19% of the trials prior or additional use of other analgesia was
an exclusion criteria (Carstoniu 1994; Chia 1990; McLeod 1985;
Rezaeipour 2008; Talebi 2009). In 50% of the trials additional or
prior use of other analgesia was unclear (Abboud 1981; Abboud
1995; Arora 1992; Cheng 2001; Einarsson 1996; Ji 2002; MRC
1970; Shao 2000; Swart 1991; Wang 1994; Wee 1993; Yeo 2007;
Zhang 2001). In 31% of the trials prior or additional use of other
analgesia was available and used by the participants but not con-
trolled for in the analysis of the effect estimate. Due to the fact
that use of other analgesia can influence women’s perception of
the use of inhaled analgesia, results must be taken with caution.
The findings of this review may not be applicable to current prac-
tice due to the differences in obstetric care in different countries
worldwide, especially for low-risk women. Nitrous oxide is rela-
tively inexpensive, has no pungent smell and is easy to administer
by the women themselves with the right equipment and circum-
stances. It can also be used in primary care which means labouring
women under supervision of primary care midwives or general
practitioners. These births can take place either in a hospital, in a
birthing centre or at home.
Inhaled analgesia from the flurane derivatives are also relatively
inexpensive depending on which agent is used. They may be more
expensive if the agent still has a patent. However, administration
of these agents needs to be controlled by a well trained anaesthe-
sia professional in order to ensure the right concentration of the
agent and thus prevent unconsciousness or other administration
problems. This is probably the main reason why use of flurane
derivatives is not widespread and also why little research is done
on this form of inhaled analgesia for the management of labour
pain.
Quality of the evidence
The ’Risk of bias’ tables (Figure 1; Figure 2) demonstrate that
inhaled analgesia has not been consistently subjected to consistent
rigorous study. The quality of reporting was poor in over 50% of
trials. The risk of bias was low in respect of randomisation (27%
and 11%). In all the other trials randomisation was unclear. Not
one trial was rated at a low risk of bias on all domains. For many
studies, blinding of participants and personnel was not possible
because of the different smells of different agents and the use of
different apparatus. In many studies there was no information
on blinding, and reporting indicated that the influence on the
outcomes was unclear, with only 11% of the trials being at low
risk of this bias. In 50% of the trials, the rates of follow-up were
high, with only a small number of trials reporting a relatively
substantial loss of participants. The small numbers of trials within
comparisons and lack of high-quality trials suggests there remains
insufficient evidence of a consistent treatment effect from inhaled
analgesia. We contacted some authors of trials in order to request
additional methodological and statistical information. However,
only one author responded (Wee 1993).
The quality of evidence was affected by unexplained heterogeneity
in some comparisons arising from both the heterogeneity of the
clinical interventions, outcome assessments, and study designs.
The small numbers of trials within comparisons, and lack of high-
quality trials prevented further exploration of heterogeneity to
assess its impact on treatment effects.
It is questionable whether the findings of the old study of Enrile
1973 can still be generalised to the current situation. Any paper
from 1973 that looks at caesarean section rate and postpartum
haemorrhage from a generation ago has to now be interpreted in
the context of a period when the caesarean section rate was less
than 10%, as well as many other changes to clinical practice.
Potential biases in the review process
We attempted to minimise publication bias. The search was com-
prehensive and there were no language restrictions.However, some
of the articleswere inChinese and Iranian, and although thesewere
translated, it is not possible to rule out the possibility of missed
data. The variation in the duration, concentration, administration
and concurrent or prior use of other analgesia suggest that inhaled
analgesia may not have been therapeutically effective and in some
cases may not represent best clinical practice.
Agreements and disagreements with other
studies or reviews
There is no other systematic review with meta-analysis of inhaled
analgesia. Nevertheless, there is one other systematic review with-
out meta-analysis of nitrous oxide as inhaled analgesia for relief of
labour pain (Rosen 2002). Rosen 2002 included studies that were
excluded from this review because we were unable to ascertain the
randomisation details or because the trial did not meet our eligibil-
ity criteria. Nevertheless, our findings and conclusions concerning
the role of inhaled analgesia for the comparisons of nitrous oxide
for pain relief in labour are similar (Rosen 2002). Rosen 2002
suggests that inhaled analgesia offers safe, reasonably effective pain
relief for many women. However, our review also highlights some
of the adverse effects (such as nausea and drowsiness) associated
with some types of inhaled analgesia such as nitrous oxide with
our meta-analysis.
A U T H O R S ’ C O N C L U S I O N S
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Implications for practice
Despite limitations in the ’Risk of bias’ assessment of the ran-
domised clinical trials with regards to trial design and representa-
tion of the results in the papers, the statistically significant results
for reduction in pain intensity and increase in pain relief indicates
that inhaled analgesia may be a useful form of pain management
for some women in labour. Inhaled analgesia may be beneficial for
those women in labour who want to have some form of pharma-
cological pain relief, without invasive methods. It was not possible
to draw any conclusions in relation to poorer outcomes for the
newborns or the mothers due to a paucity of evidence.
Implications for research
Further randomised controlled trials should be adequately pow-
ered and include relevant clinical outcomes as described in this
review especially for three primary outcomes: 1) sense of control
in labour and 2) satisfaction with childbirth and 3) breastfeeding
experience of women. Particularly studies without the confound-
ing factor of co-administration of other analgesia, would be very
helpful. Moreover, there is a need for improving the quality and
relevant, uniform reporting of future cross-over trials tomake these
trials useful to incorporate in a systematic review. It is highly de-
sirable that authors report the results from each treatment in each
period separately (Elbourne 2002). Cost-benefit analysis should
be incorporated, whenever possible, into the design of future stud-
ies.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Abboud 1981
Methods Randomised control trial conducted inDepartment ofObstetrical Anesthesia, University
of Southern California, Los Angeles, California, USA
Participants 105 participants, 50 in the experimental group and 55 in the controls
Inclusion criteria: healthy parturients undergoing normal delivery
Interventions Experimental group received continuous 30% to 60% N2O titrated by an anaesthesi-
ologist, while control group received continuous Enflurane 0.25% to 1.25% based on
anaesthesiologist titration, mean 0.5%, both during second stage of labour
Outcomes Satisfactory pain relief and use again for future delivery, Total blood loss, fluoride levels
serum and urine, Apgar score, cord blood gases, values for biochemical findings in
maternal blood and urine and in neonatal urine
Notes Not controlled for concurrent or prior use other analgesia.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomly assigned.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participant and clinician are both unaware
of which drug is administered
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
Low risk None.
Selective reporting (reporting bias) Low risk All prespecified outcomes reported upon.
Other bias Unclear risk Both groups comparable but not controlled
for prior or concurrent use of other analge-
sia
Correct analyses for cross-over design used Low risk Not cross-over design.
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Abboud 1995
Methods Randomised control trial conducted in Department of Anesthesiology, Los Angeles
County and University of Southern California Medical Center, Los Angeles, California,
USA
Participants 80 participants, 40 in each group.
Inclusion criteria: healthy parturients undergoing normal vaginal delivery
Exclusion criteria: any clinical significant history of gastrointestinal hepatic, renal, en-
docrine or respiratory disease, convulsive or neurological disorder, fetal distress, any his-
tory of chronic alcohol or drug use
Interventions Experimental group received Desflurane 1% to 4.5% and oxygen during second stage of
labour, while control group received nitrous oxide, 30% to 60% oxygen during second
stage of labour
Outcomes Patient, anaesthesiologist and obstetrician assessment of quality of pain relief. Patient
willingness to receive again the same agent. Blood loss estimated the obstetrician, Apgar
score at 1 and 5 minutes, cord acid base status and NASC at 2 and 24 hours of age of the
baby, Hb, Ht, before use of analgesia and after 12 and 24 hours postpartum, osmolality
and sodium ion concentrations of urine of the mother at the same time postpartum
Notes No information regarding concurrent or prior use of analgesia
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomly assigned using computer gener-
ated randomisation table
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Patient, obstetrician and paediatrician un-
aware of drug.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
Low risk None.
Selective reporting (reporting bias) Low risk All prespecified outcomes reported upon.
Other bias Unclear risk Both groups comparable but not controlled
for prior or concurrent use of other analge-
sia
Correct analyses for cross-over design used Low risk Not cross-over design.
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Arora 1992
Methods Single cross-over study conducted in Department of Anaesthetics, Aberdeen Royal In-
firmary, Foresterhill, Aberdeen, UK
Participants 39 participants, 20 in the experiment group and 19 in the controls
Inclusion criteria: patients in normal labour with regular painful uterine contractions
who required inhalation analgesia.
Interventions Experimental group received Entonox-isoflurane 0.25%, while control group received
Entonox (50% nitrous oxide premixed in oxygen) in first stage of labour during 5
consecutive contractions
Outcomes Pain relief, patient’s responsiveness, patient’s cooperation, reaction to odour and any
adverse effects
Notes 6th contraction wash-out period with room air (supposed to be minimal 4 exhalation)
Afterwards trial there was use of other anaesthetics during labour
No information regarding concurrent or prior use of analgesia
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number sequence.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk The Oxford Miniature Vaporizer (OMV)
was concealed in a box from the view of
both investigator and mother but 1 agent
has a particular smell (blinding not possi-
ble), unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 women, unable to come to any decision
on a linear analogue scale scores for pain
relief
Selective reporting (reporting bias) High risk Baby outcomes not clear.
Other bias Unclear risk None apparent but not controlled for prior
or concurrent use of other analgesia
Correct analyses for cross-over design used High risk Paired samples using Wilcoxon Rank Sum
Test but mean/SD for experimental inter-
vention alone and control (intervention)
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Arora 1992 (Continued)
alone, not possible to extract paired data
Arthurs 1979
Methods This trial was conducted in Maelor General Hospital, Wrexham, UK. 3 studies were
conducted in this trial:
Kinetic studies: observational study, the expired concentration of nitrous oxide was
measured and recorded continuously with a mass spectrometer to measure themaximum
concentrations and the end-tidal nitrous oxide concentration and its effects on mothers
and babies
Within patient studies: observational study to measure patient preference.
Between patient studies: randomised trial, comparing self-administration of Entonox
with a nasal supplement of Entonox with self-administration of Entonox with no nasal
supplement for the evaluation of pain, mothers opinion, midwives opinion, acceptability
of nasal catheter and maximum tolerable flow
Participants 49 participants 24 in the study group and 25 in the control group
Interventions Experiment group received self-administered Entonox and continuous nasal supplement
of Entonox and controls received self-administered Entonox and no continuous nasal
inhalation, probably during first and second stage of labour (“recording until delivery”)
Outcomes Pain on linear analogue after 2, 4, 6 contractions, pain rated immediately after delivery
and between 24 and 48 hours later, how much inhalation helped, satisfaction with pain
relief (memory of pain in labour), nausea and vomiting, caesarean section, Apgar score
- mean at 1 and 5 minutes, pain relief as assessed by midwives
Notes Only data from between patient studies used in this review.
Opiods also available.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomly allocated.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not reported.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
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Arthurs 1979 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported.
Selective reporting (reporting bias) High risk Pain data after 6 contractions and immedi-
ately after delivery not reported
Other bias Unclear risk Baseline characteristics seems comparable
but other opioids also available and no in-
formation of the use of these other analge-
sia
Correct analyses for cross-over design used Low risk Not cross-over design.
Belfrage 1974
Methods Randomised trial conducted in Karolinska Sjukhuset Hospital, Stockholm, Sweden
Participants 98 participants, 47 in the experiment group and 51 in the control group
Interventions Experiment group received 0.3% to 0.8% of Methoxyflurane and controls received
nitrous oxide 70% with 30% oxygen in second stage of labour
Outcomes Pain scores, assisted vaginal birth, caesarean section.
Notes Concurrent or prior use of pethidine.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Women were randomly divided into 2
groups.
Allocation concealment (selection bias) Unclear risk Women were randomly divided into 2
groups.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear from translation.
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Belfrage 1974 (Continued)
Selective reporting (reporting bias) Unclear risk Unclear from translation.
Other bias Unclear risk No baseline characteristics and concurrent
use of pethidine in both groups
Correct analyses for cross-over design used Low risk Not cross-over design.
Bergsjo 1971
Methods Randomised single cross-over trial conducted in Aker Hospital Oslo, Norway
Participants 63 participants, 26 in the experiment group and 37 in the control group
Inclusion criteria: women in established labour with obvious pain and expected labour
to be normal
Exclusion criteria: history of liver and kidney disease.
Interventions Experimental group received Nitrous oxide mixed with oxygen in 50% concentration
inhaled intermittent, followed by methoxyflurane, while control group received first 0.
5% to 0.8% methoxyflurane, inhaled intermittent, followed by nitrous oxide/oxygen
50% in first stage of labour during 3 consecutive contractions
Outcomes Drug of preference, degree of analgesic effect, unpleasant subjective side effects, other
side effects scored by observer, Apgar scores, total labour time and additional drugs
needed after the trial stopped
Notes A wash-out period of 1 contraction with air breathing.
Concurrent or prior use of opioids or diazepam.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A list of random numbers.
Allocation concealment (selection bias) Low risk List of random numbers to decide in which
order the drugs are given owned by office
personnel, not seen by the doctors
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Entonox is inhaled through anaesthetic
face masks working by inhaled flow, and
methoxyflurane is inhaled by a specially
made Analgizer which is a cylindrical tube
with a mouthpiece
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Bergsjo 1971 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Entonox is inhaled through anaesthetic
face masks working by inhaled flow, and
methoxyflurane is inhaled by a specially
made Analgizer which is a cylindrical tube
with a mouthpiece
Incomplete outcome data (attrition bias)
All outcomes
Low risk 3 participants did not scored their prefer-
ence.
Selective reporting (reporting bias) Low risk All prespecified outcomes reported upon.
Other bias Unclear risk 1 group older, but should have no impact
on results, prior or concurrent use of opi-
oids or diazepam
Correct analyses for cross-over design used Unclear risk Single cross-over design.
Carstoniu 1994
Methods Single cross-over randomised trial conducted in Toronto Hospital, Toronto, Ontario,
Canada
Participants 26 participants, 14 in the experimental group and 12 controls
Exclusion criteria: age < 18 years, maternal cardiorespiratory disease, fetal distress, any
condition affecting the accuracy of pulse oximetry or the use of opioids or regional
anaesthesia
Interventions Experimental group received self-administered 50% nitrous oxide and oxygen for 5 con-
secutive contractions. For the next 5 contractions compressed air was self-administered.
Control group received same gases in reverse order. Used in first stage of labour
Outcomes VAS pain scores, the lowest Spo2 (maternal haemoglobin oxygen saturation) observed
after a contraction, ability correctly to identify the order of the gases in the 2 groups,
only reported in figures
Notes No wash-out period (comparison with compressed air).
No concurrent or prior use of other analgesia.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table.
Allocation concealment (selection bias) Low risk Numbered sealed envelopes.
35Inhaled analgesia for pain management in labour (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Carstoniu 1994 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Valves hidden from participants but nurses
are the ones hiding it and who open ran-
domisation envelope
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk 3 participants excluded for not completing
the trial.
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk Both groups comparable.
Correct analyses for cross-over design used Unclear risk Data for paired groups only in figures, not
possible to extract paired data
Cheng 2001
Methods Randomised controlled trial conducted in Third Affiliated Hospital, Henan Medical
University, Zhengzhou, China
Participants 75 participants, 25 in each group.
Inclusion criteria: healthy full term 22-30 years old singleton vertex presentation prim-
ipara
Interventions Group 1 received isoflurane 0.2% to 0.75% and oxygen.
Group 2 received nitrous oxide 30% to 50% and oxygen.
Group 3 - controls - received air.
Outcomes Pain intensity - effectiveness of inhalation analgesia, duration of each stage of labour,
mode of delivery, postpartum haemorrhage, gas analysis of neonatal umbilical artery and
vein, Apgar score and NACS
Notes Concurrent or prior use of other analgesia not known.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomly.
Allocation concealment (selection bias) Unclear risk Not reported.
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Cheng 2001 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Semi-closed anaesthetic method.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Semi-closed anaesthetic method.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported.
Selective reporting (reporting bias) High risk Data on pain intensity and mode of deliv-
ery reported upon in another article which
was not referenced
Other bias Unclear risk No baseline characteristics and prior or
concurrent use of other analgesia unknown
Correct analyses for cross-over design used Low risk Not cross-over design.
Chia 1990
Methods This study was conducted in National University Hospital, Singapore in 2 parts. Part I
is a quasi-randomised trial and part II is a cross-over trial, first period data available
Participants 20 participants, 10 in each group. Inclusion criteria were nulliparous who were to have
surgical induction of labour and exclusion criteria included desire for epidural analgesia,
in advanced labour or given any other form of analgesia
Interventions Group C received TENS and group D received Entonox (a switch over of the modes of
pain relief was made when labour pain was no longer tolerable; patient using TENS was
commenced on Entonox and vice versa). Any use of wash-out time or time indication
of switch-over period not reported
Outcomes Pain intensity, satisfaction with pain relief (nil, partial, complete), birthweight admission
to NICU and Apgar score
Notes Only data from part II trial used in this review. Any information of wash-out period is
not reported
No prior or concurrent use of other analgesia (excluded).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomised.
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Chia 1990 (Continued)
Allocation concealment (selection bias) Low risk “randomly allocated by use of sealed en-
velopes.”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not reported.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported.
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk Both groups are comparable, no use of
other analgesia.
Correct analyses for cross-over design used Low risk Only use of part II, this part is a randomised
controlled trial (parallel groups)
Einarsson 1996
Methods Randomised controlled trial conducted inDeptObstetrics andGynaecology, Sahlgrenska
University Hospital, Sweden
Participants 24 participants, 12 in each group.
Inclusion criteria: women undergoing vaginal delivery.
Exclusion criteria: maternal cardiorespiratory disease, pre-eclampsia, any evidence of fetal
distress or used opioid or regional analgesia
Interventions Experimental group received 50% nitrous oxide and control group received 70% nitrous
oxide
Outcomes Inspiratory and end-tidal (E’) concentrations of carbon dioxide (CO2), oxygen and
nitrous oxide, pulse oximetry (Spo2) respiratory rate, tidal volume and expiratory minute
ventilation volume (VE).
Notes No information regarding use of prior or concurrent other analgesia, but presumably
not because intervention started when women first requested analgesia
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Allocated randomly.
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Einarsson 1996 (Continued)
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not reported.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss.
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Unclear risk Both groups comparable but no informa-
tion of use of other analgesia
Correct analyses for cross-over design used Low risk Not cross-over trial.
Enrile 1973
Methods Randomised controlled trial conducted in Cleveland Metropolitan General Hospital,
Cleveland, Ohio, USA
Participants 26 participants, 14 in the experiment group and 12 in the controls
Inclusion criteria: American Society of Anaesthesiologists classification of physical status
(ASA) Class 1 or 2
Interventions Both groups received Methoxyflurane but the experiment group used Analgizer while
controls used Cyprane Inhaler
Outcomes Cord blood PH, Methoxyflurane concentration in maternal blood, Apgar score (2 miss-
ing in Cyprane group), orientation, motor co-ordination, level of analgesia, level of am-
nesia, caesarean section, satisfaction with analgesia, nausea and vomiting
Notes Inhaler and pudendal block possible (7p in Cyprane, 7p in Penthrane), and spinal (3p
in Cyprane, 5p in Penthrane)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation table.
Allocation concealment (selection bias) Unclear risk Not reported.
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Enrile 1973 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not reported but both delivery systems
completely different from each other
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not reported but both delivery systems
completely different from each other
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported. 2 missing in Cyprane group
for Apgar score is less than 20% (low risk
of bias)
Selective reporting (reporting bias) High risk Some of outcomes incompletely reported
upon -results reported for only 1 of the
groups, e.g. evaluation of pain, satisfaction
pain relief, nausea and vomiting
Other bias High risk The patients utilising a mask attached to
the analgizer obtained better pain relief
than those using the analgizer without
a mask because the diluter hole in the
analgizer was left open during administra-
tion resulting in a lower concentration of
Methoxyflurane available for inhalation
Correct analyses for cross-over design used Low risk Not cross-over trial.
Ji 2002
Methods Randomised controlled trial conducted in Qingdao Municipal Hospital, Qingdao,
China. From January 2001 to November 2001
Participants 300 participants, 100 in each arm.
Inclusion criteria: primiparous with single fetus, no significant cephalopelvic dispropor-
tion, with no contraindications to anaesthesia
Interventions Group 1 received combined spinal epidural analgesia.
Group 2 received 50% nitrous oxide and 50% oxygen, at a rate of 0-15 L every minute
Controls received no treatment.
Outcomes Analgesic effect, duration of labour, method of delivery, postpartum bleeding, rate of
newborn anoxia, maternal radial artery blood for blood gas analysis and fetal umbilical
blood for blood gas analysis
Notes Only data from group 2 (nitrous oxide) versus control included in this review
Control groupdidnot receive any analgesia, no information regardingprior or concurrent
use of other analgesia in nitrous oxide group
40Inhaled analgesia for pain management in labour (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ji 2002 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated as per translation.
Allocation concealment (selection bias) Unclear risk Not stated as per translation.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not stated as per translation.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated as per translation.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not stated as per translation.
Selective reporting (reporting bias) Low risk All prespecified outcomes reported upon.
Other bias High risk No baseline characteristics, no information
of use of other analgesia in nitrous oxide
group
Correct analyses for cross-over design used Low risk Not cross-over trial.
Jones 1969
Methods Randomised control trial conducted in Department of Anaesthetics, Royal Infirmary,
Cardiff, UK
Participants 48 participants, 24 in each group.
Inclusion criteria: normal labour.
Exclusion criteria: received instruction in psychoprophylaxis or hypnosis
Interventions Experimental group received methoxyflurane continuous, while control group received
nitrous oxide continuous
Outcomes Efficacy assessment by 4-point scale just after delivery, nausea during labour (intrapartum
or first 24 hours), vomiting, dreams and Apgar score 1 minute
Notes Prior use of pethidine in the 4 hours preceding the beginning of inhalation (11p N2O-
group, 14p meth.-group),
Risk of bias
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Jones 1969 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Random basis.
Allocation concealment (selection bias) Unclear risk Random basis.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not described.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
High risk 2 mothers not questioned after birth be-
cause of stress (abnormal child and severe
nausea and vomiting).
Selective reporting (reporting bias) Low risk All prespecified outcomes reported upon.
Other bias Unclear risk Both groups comparable but use of pethi-
dine as analgesia prior
Correct analyses for cross-over design used Low risk Not cross-over trial.
Jones 1969a
Methods Randomised control trial conducted in Department of Anaesthetics, Royal Infirmary,
Cardiff, UK
Participants 50 participants, 25 in each group.
Inclusion criteria: normal labour.
Exclusion criteria: received instruction in psychoprophylaxis or hypnosis
Interventions Experimental group received self-administered intermittent N2O 50%, while control
group received self-administered intermittent methoxyflurane 0.35%
Outcomes Assessment of efficacy by 4-point scale just after delivery, nausea, vomiting, hazymemory,
noted the smell of the gas, dreams, numbness or buzzing in the ears or ’pins and needles’,
Apgar score 1, 2, 5 and 10 minutes
Notes Concurrent or prior use of pethidine (64% meth. group, 68% N2O group)
Risk of bias
Bias Authors’ judgement Support for judgement
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Jones 1969a (Continued)
Random sequence generation (selection
bias)
Unclear risk Random basis.
Allocation concealment (selection bias) Unclear risk Random basis.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not described.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
Low risk None.
Selective reporting (reporting bias) Low risk All prespecified outcomes reported upon.
Other bias Low risk Both groups comparable (also comparable
in prior use of pethidine)
Correct analyses for cross-over design used Low risk Not cross-over trial.
McGuinness 1984
Methods Randomised cross-over trial conducted in Department of Anaesthetics, University Hos-
pital of Wales, Heath Park, Cardiff, UK
Participants 20 participants, 20 measurements for each intervention, total 40 measurements
Inclusion criteria: fit women who were in early normal labour
Interventions Experimental group received enflurane during 3 consecutive contractions (no wash-out
time used), while control group received Entonox (50% N2O and 50% O2) during 3
consecutive contractions
Outcomes Pain assessment with linear analogue scale, drowsiness and nausea by linear analogue
scale
Notes No wash-out time between agents.
Concurrent or prior use of opioids before or during use of N2O
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described.
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McGuinness 1984 (Continued)
Allocation concealment (selection bias) Unclear risk Randomly given 1 of the analgesic agents.
Not described how.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk The orientation of the tap (agents delivered
via the same tubing and mouthpiece) was
concealed from the operator
Different odour of agents, not described.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
Low risk None.
Selective reporting (reporting bias) Low risk All prespecified outcomes reported upon.
Other bias Unclear risk Both groups comparable, prior or concur-
rent use of pethidine in 1 group
Correct analyses for cross-over design used High risk Linear analogues scales were compared
with the Wilcoxon matched-pairs signed-
rank test, but no data of individual pa-
tients.Overall median/range of experimen-
tal group and comparison group separately,
not possible to extract paired data
McLeod 1985
Methods Randomised cross-over trial conducted in Department of Anaesthetics, Aberdeen Royal
Infirmary, Foresterhill, Aberdeen, UK
Participants 32 participants with 31 measurements of entonox and 31 measurements of isoflurane
Inclusion criteria: in ASA 1 group (completely healthy patient), in normal established
labour, requiring analgesia
Exclusion criteria: receiving any other analgesic or sedative agent during labour
Interventions Experimental group received Isoflurane 0.75% during 5 consecutive contractions in first
stage of labour (with a break of 2 contractions to allow of elimination of the first agent)
, while control group received nitrous oxide during 5 consecutive contractions in first
stage of labour
Outcomes Linear analogue scores for pain measured before starting the trial (0 point) and after each
contraction, drowsiness measured after the 5 contractions of each agent, comment of
both analgesics and patients preference after delivery
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McLeod 1985 (Continued)
Notes Wash-out period of 2 contractions.
No concurrent or prior use of opioids (were excluded). Total 31measurements of Entonox
and total 31 measurements of Isoflurane, in total 62 measurements, unknown why not
64 measurements, probably one women did not completed the study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ’Randomized’, not described.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not described.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 because of smell of isoflurane.
Selective reporting (reporting bias) Low risk All prespecified outcomes reported upon.
Other bias Low risk Both groups comparable.
Correct analyses for cross-over design used High risk Pain scores were compared using the
Wilcoxon rank sum test for paired samples
but no data of individual patients. Overall
mean/range of experimental and compari-
son group separately, not possible to extract
paired data
MRC 1970
Methods Randomised trial conducted in 7 hospitals: Aberdeen Maternity Hospital, Cardiff Royal
Infirmary and Maternity Hospital, Simpson Memorial Maternity Pavilion (Edinburgh)
, Hammersmith Hospital, Kingsbury Maternity Hospital, Kingston Hospital and West-
minster Hospital
Participants 601 participants, 259 in the experiment group and 242 in the control group
Exclusion criteria: multiple birth expected or if special delivery procedures were likely to
be needed
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MRC 1970 (Continued)
Interventions Experimental group received intermittent 50% nitrous oxide, while control group re-
ceived intermittent 70 % nitrous oxide
Outcomes Pain assessment , drowsiness and nausea, dreams, side effects
Notes No information regarding concurrent or prior use of other analgesia
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not described.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
High risk 21 were excluded from the initial analysis,
12 because they had given birth to twins
and 9 because the information on the forms
was incomplete. Also 277 cases were ex-
cluded from the main analysis, some being
rejected for more than 1 reason
Selective reporting (reporting bias) Low risk All prespecified outcomes reported upon.
Other bias Unclear risk Both groups comparable but no informa-
tion of prior or concurrent use of other
analgesia
Correct analyses for cross-over design used Low risk Not cross-over trial.
Rezaeipour 2008
Methods Randomised controlled trial conducted in Orumieh Hospital, Tehran, Iran
Participants 155 participants, 78 in the experiment group and 77 in the control group
Inclusion criteria: primipara, 18-35 years of age, not have used any anaesthesia, not for
inducing labour. With no restrictions in using Entonox (due to respiratory problems,
pneumothorax, and trauma to the head in the past) and have dilated 4 cm
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Rezaeipour 2008 (Continued)
Exclusion criteria: any complications during labour and delivery and the need to induce
labour
Interventions Experiment group received Entonox while control group inhaled oxygen
Outcomes Pain as measured by VAS, mothers vital signs, fetal heart rate, Apgar score at 1 and 5
minutes, postpartum haemorrhage, mode of delivery, side effects for mother (drowsiness
and mouth stiffness) and satisfaction with delivery
Notes No use of prior or concurrent other analgesia.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Single blinding.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Single blinding.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 women from the intervention (Entonox)
group and 3 from the control group had to
be excluded from the study due to the need
for emergency caesarean sections
Selective reporting (reporting bias) Unclear risk Not clear from translation.
Other bias Unclear risk No baseline characteristics.
Correct analyses for cross-over design used Low risk Not cross-over trial.
Shao 2000
Methods Randomised parallel study conducted from20thMay to 9thDecember 1998 inZhejiang
Yuyao People’s Hospital, Yuyao, China.
Participants 250 participants, 125 in each group.
Interventions Experiment group inhaled the laughing gas and control group no treatment
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Shao 2000 (Continued)
Outcomes Pain intensity (degree of labour pains), method of delivery, Apgar scores, intrapartum
haemorrhage, postpartum haemorrhage, other side effects (mild dizziness, fatigue and
sleepiness)
Notes No information regarding other used analgesia.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated.
Allocation concealment (selection bias) Unclear risk No information as per translation.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information as per translation.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information as per translation.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information as per translation.
Selective reporting (reporting bias) Unclear risk Can not tell completely from the transla-
tion.
Other bias Unclear risk No information as per translation, no in-
formation of use of other analgesia
Correct analyses for cross-over design used Low risk Not cross-over trial.
Stefani 1982
Methods Randomised control trial conducted in University Hospital Southern California, USA
Participants 61 participants, 22 in the experiment group1, 18 in the experiment group 2 and 21 in
the controls
Inclusion criteria: healthy full-term parturients.
Interventions Experimental group 1 received enflurane 0.3% to 0.8%, experimental group 2 received
nitrous oxide (30% to 50%), while control group received no treatment
Outcomes NACS using the Early Neurobehavioral Scale, satisfactory pain relief
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Stefani 1982 (Continued)
Notes Concurrent or prior use of other analgesia: 50% to 41% received no narcotics, the other
group received small doses of opioids, 66% pudendal block
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Assigned randomly.
Allocation concealment (selection bias) Unclear risk Assigned randomly.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not described.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Two examiners, blind to both the nature
and duration of analgesia simultaneously
evaluated and scored the neuro behavioural
status of infants.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk None.
Selective reporting (reporting bias) Low risk All prespecified outcomes reported upon.
Other bias Low risk Both groups comparable and use of other
analgesia in both groups seems similar
Correct analyses for cross-over design used Low risk Not cross-over trial.
Swart 1991
Methods Randomised trial conducted in Department of Anesthesiology, Los Angeles County -
University of southern California Medical Centre, Los Angeles, California, USA
Participants 60 participants, 30 in each group.
Interventions Experimental group received desflurane 1% to 4.5% and oxygen while control group
received nitrous oxide 30% to 60% and oxygen
Outcomes Analgesia assessment, blood loss, Apgar score, blood acidity and NACS
Notes Abstract (poster session) only - data limited.
No information regarding concurrent or prior use of other analgesia
Risk of bias
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Swart 1991 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomly assigned.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Both patient and obstetrician did not know
the gas.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported.
Selective reporting (reporting bias) Unclear risk There is insufficient information about the
numerical results in the abstract
Other bias Unclear risk Groups characteristics not reported in the
abstract.
Correct analyses for cross-over design used Low risk Not cross-over trial.
Talebi 2009
Methods Randomised control trial conducted from September 2004 to 2006 in Department of
Anaesthesiology, Arak University Hospital, Arak, Iran
Participants 534 ASA I and II parturients, 260 in experimental group and 249 in control group
Inclusion criteria: scheduled for elective labour, term (38-42 weeks) in active stage of
labour (dilation more then 4 cm).
Exclusion criteria: any evidence of fetal distress, or abnormal fetal heart pattern, maternal
cardiorespiratory disease or any condition effecting the accuracy of pulse oximetry, history
of taking opioids, administrations of sedation or regional analgesia (pudendal block,
local infiltration), intolerance of Entonox, during trial when birth ended in caesarean
section or forceps
Interventions Experimental group received self-administration of pre-preparedmixture of 50% nitrous
oxide and oxygen started as early as the onset of pain with each contraction (when patient
first requested analgesia), while control group received self-administration of 50%oxygen
as early as the onset of pain with each contraction
Outcomes Pain scores of contractions by VAS (time at the start of inhaled analgesia and every
hour from time 1 to 5), the lowest spO2 (by pulse oxymeter) and mean arterial blood
pressure of themother, Apgar scores of 1 and 5minutes postpartum. Side effect as nausea,
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Talebi 2009 (Continued)
vomiting dizziness, dry mouth from gas, pins and needles or numbness and drowsiness
measured at the end of the study
Notes No concurrent or prior use of other analgesia (excluded).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation with a coin.
Allocation concealment (selection bias) Unclear risk Randomisation with a coin.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not described.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Participants rating of pain was recorded by
someone blind to allocation, plus arterial
pressure and Apgar score
Incomplete outcome data (attrition bias)
All outcomes
Low risk 4 of 523 loss to follow-up. No patient ex-
cluded after randomisation. Intention to
treat not known
Selective reporting (reporting bias) Low risk All prespecified outcomes reported upon.
Other bias High risk More primipara in nitrous oxide group.
This would be in favour of control group
regarding pain.
Correct analyses for cross-over design used Low risk Not cross-over trial.
Wang 1994
Methods Randomised study conducted inTheThirdAffiliatedHospital ofHenanMedical School,
China
Participants 84 participants, 34 in the experiment group and 50 controls.
Interventions Experiment group received nitrous oxide and control group received no treatment
Outcomes Analgesic effects, respiratory and circulatory functions, uterine contractions, progress of
labour, Apgar score and postpartum bleeding
Notes No information of prior or concurrent use of other analgesia
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Wang 1994 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not reported.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported.
Selective reporting (reporting bias) Unclear risk Only the abstract translated.
Other bias Unclear risk Only the abstract translated.
Correct analyses for cross-over design used Low risk Not cross-over trial.
Wee 1993
Methods Randomised cross-over trial conducted in St Michael’s Hospital, Bristol, UK
Participants 18 participants with 17 measurements of drowsiness and 18 measurements of pain
intensity after 1 hour in first period before the first cross-over ended
Inclusion criteria: between 16 and 38 years old, in ASA grade 1, in normal labour and
requesting inhalation analgesia (mothers were allowed to opt out if inhalational analgesia
subsequently proved to be unsatisfactory)
Interventions Experimental group received E-I-E sequence, mothers inhaled Entonox alone at the
first hour, Entonox and 0.2% Isoflurane for the second and Entonox alone for the
third hour, while control group received I-E-I sequence, mother inhaled Entonox and
0.2% isoflurane at the first hour, Entonox alone for the second and Entonox and 0.2%
isoflurane for the third hour
Outcomes Pain and drowsiness assessmentmeasured with VAS, baseline score before any inhalation,
subsequently scores recorded at 20 minutes intervals, obtained as soon as possible after
each contraction during the hour of 1 agent (intervention and comparison group), baby
Apgar score 1 and 5 minutes. The differences in median scores in both groups between
baseline and the first hour, the first and the second hour, the second and the third hour
were calculated
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Wee 1993 (Continued)
Notes No information on wash-out period between agents but inhalation agent was used for
1 complete hour and efficacy was scored after 20 minutes. Moreover the inhalation
gases were self-administered during contractions. This means that the minimal wash-
out period of 4 exhalations must have passed during the pauses between contractions
Probably no prior or concurrent use of other analgesia because women were allowed
to drop out if analgesia was not satisfactory. We used only data of the first period
(measurements after 1 hour) with 18 participants and 11 measurements of Entonox use
and 8 measurements of Isoflurane/Entonox use
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not described.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 woman did not complete the study.
Selective reporting (reporting bias) Low risk All prespecified outcomes reported upon.
Other bias Unclear risk Baseline not reported for the 2 groups, no
information about other additional drugs
Correct analyses for cross-over design used High risk Probably paired t-test in this trial (no in-
formation).
Overall mean/SD for experimental and
comparison groups separately calculated by
individual data for first period after one
hour, analysed as parallel group data
Yeo 2007
Methods Randomised, open label, double cross-over trial conducted in Anaesthetic Department,
The County Hospital, Union Walk, Hereford, UK
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Yeo 2007 (Continued)
Participants 31 participants, 15 in the experiment group and 16 in the controls with 37measurements
of Entonox and 43 measurements of enflurane
Inclusion criteria: active labour (≥ 3 cm cervical dilatation) with contractions occurring
at least 1 every 3 minutes, spontaneous or induced, ≥ 37 weeks’ gestation with prior
consent
Exclusion criteria: women who had no knowledge of the study before, major uterine ab-
normalities, multiple gestation, cardiovascular or respiratory instability, acute or chronic
obstetric pathology and women who received any analgesia before recruited
Interventions Experimental group received Entonox/Sevoflurane 0.7%/Entonox (ESE), each agent
during 10 contractions, while control group received Sevoflurane 0.7%/Entonox/Su-
voflurane 0.7% (SES), each agent during 10 contractions. Between each agent a wash-
over period of breathing room air during 1 contraction, participant could omit this wash-
over period if they wished
Outcomes VAS of overall pain relief with each contraction, pain intensity, sedation, mood and
coping before and after each of 10 contractions with a specific agent, inspired and ex-
pired gas concentration, maternal ventilator frequency, intermittent non invasive arterial
pressure, heart rate and maternal arterial oxygen saturation, fetal heart rate and maternal
contractions on cardiotocograph, type of analgesia used after trial, mode of delivery, and
preferred agent scored within 48hours after delivery
Notes Between agent a wash-out period during 1 contraction, participant could omit this
wash-over period if they wished (no information on numbers) but the agents were self-
administered so probably there was a minimum of 4 exhalations between the 2 agents
No prior use of other analgesia before treatment (excluded), no information on con-
current use. We extracted 43 measurements with Enflurane and 37 measurements with
Entonox
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ‘randomised.’
Allocation concealment (selection bias) Unclear risk ‘randomised.’
Blinding of participants and personnel
(performance bias)
All outcomes
High risk ‘open label.’
Blinding of outcome assessment (detection
bias)
All outcomes
High risk ‘open label.’
Incomplete outcome data (attrition bias)
All outcomes
High risk 2 women withdrew after the first con-
traction because of unpleasant odour of
sevoflurane (preferred Entonox), 1 woman
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Yeo 2007 (Continued)
withdrew before inhalation of any admin-
istration (requested an epidural), these 3
womenwere not followed up because of the
early withdrawal (before first cross-over)
5 withdrew because of requested epidural
analgesia whilst in the Entonox phase of the
study, 4 in the ESE group in the last phase
using Entonox and 1 in the SES group, 2
withdrawals because of starting the second
stage of labour before ending the trial
Selective reporting (reporting bias) Low risk Aall prespecified outcomes reported upon.
Other bias Low risk Both groups comparable and no use of
other analgesia.
Correct analyses for cross-over design used High risk Overall pain relief scores of experimental
and comparison groups separately
Zhang 2001
Methods Randomised study conducted inTheThirdAffiliatedHospital ofHenanMedical School,
China
Participants 110 participants, 60 in the experimental group and 50 in the control group
Interventions Experiment group received 30% to 50% nitrous oxide and oxygen 5L/minwhile controls
received only oxygen 5L/min
Outcomes Labour pain, mode of delivery, Apgar score, postpartum haemorrhage, vomiting and
neonatal asphyxia
Notes Concurrent or prior use of other analgesia not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomly chosen.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not reported.
55Inhaled analgesia for pain management in labour (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Zhang 2001 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss.
Selective reporting (reporting bias) High risk Apgar score mentioned in abstract of study,
but no results were reported within the re-
sults section of the paper
Other bias Unclear risk Not clear.
Correct analyses for cross-over design used Low risk Not cross-over trial.
ASA: American Society of Anaesthesiologists
NACS: neurologic and adaptive capacity score
NICU: neonatal intensive care unit
OMV: Oxford Miniature. Vaporizer
SD: standard deviation
VAS: visual analogue scale
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Arozenius 1980 Not randomised.
Arthurs 1981 Quasi-randomised trial.
Chessor 2005 Not randomised.
Clark 1979 Comparison with opioids which are higher than inhalation in the pain management hierarchy
Cosmi 1969 Spinal block compared to general anaesthesia study. Not randomised
Crawford 1975 Participants not women in labour. Study on general anaesthesia and it’s side effects in caesarean section
Creasser 1974 Complex intervention -all women had a pudendal block. 1 group received methoxyflurane and the other group
received intramuscular analgesia + nitrous oxide. Does not fit in with our hierarchy
Davies 1974 Quasi-randomised trial. Study mainly concerned with resistance of the delivery system
Davies 1975 Not randomised.
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(Continued)
Howell 2001 Intervention investigated was epidural and both groups received Entonox. Fits in with epidural review according
to pain management hierarchy
Krantz 1974 General anaesthesia trial and participants were not women in labour
Major 1966 Controls treatment (Trichloroethylene) not used any more since 1975. Quasi-randomised trial
Major 1967 Quasi-randomised trial.
McAneny 1963 Participants were distributed between groups and not randomised
Phillips 1971 Controls treatment (Trichloroethylene) not used any more since 1975 and all groups got pethidine
Roberts 1957 Not randomised. Comparison of nitrous oxide to opioids which are higher in the pain management hierarchy
Robinson 1980 Epidural is higher than inhalation in the pain management hierarchy
The main comparison is between opioids and inhaled analgesic versus epidural analgesia
Rosen 1969 Quasi-randomised trial.
Rosen 1972 Quasi-randomised trial. Controls were not pregnant.
Shnider 1963 Cyclopropane no longer used in practice. Study conducted during episiotomy repair after delivery
Volmanen 2005 Comparison of nitrous oxide to opioids which are higher in the pain management hierarchy
Characteristics of studies awaiting assessment [ordered by study ID]
Su 2002
Methods Unclear - article in Chinese, awaiting translation. In English abstract just states “women in labour were divided into
two groups”
Participants 1300 cases of term primiparous women in labour.
Interventions Study group (n = 658) 50% nitrous oxide in oxygen.
Control group (n = 642) intermittent inhalation of 50% oxygen
Outcomes Duration of labour; delivery mode; meconium-stained amniotic fluid; postpartum bleeding volume; neonatal Apgar
score; blood gas analysis
Notes Awaiting translation June 2012.
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D A T A A N D A N A L Y S E S
Comparison 1. Nitrous oxide versus flurane derivatives
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain intensity (VAS 0-100 first
stage)
3 70 Mean Difference (IV, Random, 95% CI) 14.39 [4.41, 24.37]
2 Pain relief (VAS 0-100 as 100 is
the most pain relief, first stage)
2 70 Mean Difference (IV, Random, 95% CI) -16.32 [-26.85, -5.
79]
3 Satisfaction with pain relief (first
and second stage, considerable
to complete)
2 98 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.80, 1.18]
4 Satisfaction with pain relief
(second stage, good to
excellent)
4 323 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.78, 1.01]
5 Assisted vaginal birth 5 371 Risk Ratio (M-H, Random, 95% CI) 0.71 [0.44, 1.15]
6 Caesarean section 1 98 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Amnesia 3 245 Risk Ratio (M-H, Random, 95% CI) 0.26 [0.03, 2.38]
8 Drowsiness (VAS 0-100 mm) 1 18 Mean Difference (IV, Fixed, 95% CI) 11.64 [-16.04, 39.
32]
9 Nausea 2 98 Risk Ratio (M-H, Fixed, 95% CI) 6.6 [1.85, 23.52]
10 Vomiting 3 203 Risk Ratio (M-H, Fixed, 95% CI) 2.02 [0.75, 5.46]
11 Blood loss in mL 2 185 Mean Difference (IV, Fixed, 95% CI) 6.0 [-32.91, 44.91]
12 Apgar score less than seven at
five minutes
5 373 Risk Ratio (M-H, Fixed, 95% CI) 0.22 [0.01, 4.47]
13 NACS < 35 at 2 hours after
delivery
3 170 Risk Ratio (M-H, Fixed, 95% CI) 1.45 [0.91, 2.33]
Comparison 2. Inhaled analgesia of one strength versus inhaled analgesia of different strength
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Satisfaction with pain relief (first
stage, good to complete)
1 501 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.94, 1.17]
2 Satisfaction with pain relief
(second stage, good to
complete)
1 501 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.87, 1.08]
3 Caesarean section 1 501 Risk Ratio (M-H, Fixed, 95% CI) 0.31 [0.06, 1.53]
4 Assisted vaginal birth 1 501 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.61, 1.14]
5 Vomiting 1 501 Risk Ratio (M-H, Fixed, 95% CI) 1.29 [0.86, 1.94]
6 Postpartum haemorrhage 1 501 Risk Ratio (M-H, Fixed, 95% CI) 0.80 [0.38, 1.70]
7 Hypoxaemia mother 1 24 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.07, 14.21]
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Comparison 3. Inhaled analgesia using one type of delivery system versus a different delivery system
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Satisfaction with pain relief
(first stage, considerable to
complete)
1 42 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.94, 1.48]
2 Caesarean section 1 26 Risk Ratio (M-H, Fixed, 95% CI) 2.6 [0.12, 58.48]
3 Vomiting (N2O + nasal) 1 49 Risk Ratio (M-H, Fixed, 95% CI) 1.76 [0.77, 4.00]
4 Vomiting dichotomous
Penthr./Cypr.
1 26 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Postpartum haemorrhage 1 26 Risk Ratio (M-H, Fixed, 95% CI) 0.29 [0.01, 6.50]
6 Mild pre-eclampsia 1 26 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.06, 12.28]
7 Apgar score (continuous, at 5
min.Penthr/Cypr)
1 24 Mean Difference (IV, Fixed, 95% CI) 0.0 [-0.37, 0.37]
8 Apgar score (continuous
N2O/N2O with nasal suppl.)
1 49 Mean Difference (IV, Fixed, 95% CI) -0.30 [-0.81, 0.21]
Comparison 4. Inhaled analgesia versus placebo control/no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain intensity (first stage,
clear/severe to intense/extreme)
2 310 Risk Ratio (M-H, Random, 95% CI) 0.06 [0.01, 0.34]
2 Pain intensity (first stage, VAS
0-10 after 1 hour)
1 509 Mean Difference (IV, Fixed, 95% CI) -3.50 [-3.75, -3.25]
3 Assisted vaginal birth 1 200 Risk Ratio (M-H, Fixed, 95% CI) 1.5 [0.44, 5.15]
4 Caesarean section 3 465 Risk Ratio (M-H, Fixed, 95% CI) 1.20 [0.75, 1.91]
5 Vomiting 2 619 Risk Ratio (M-H, Fixed, 95% CI) 9.05 [1.18, 69.32]
6 Nausea 1 509 Risk Ratio (M-H, Fixed, 95% CI) 43.10 [2.63, 706.74]
7 Dizziness 1 509 Risk Ratio (M-H, Fixed, 95% CI) 113.98 [7.09, 1833.
69]
8 Drowsiness 1 509 Risk Ratio (M-H, Fixed, 95% CI) 77.59 [4.80, 1254.
96]
9 Neonatal asphyxia 1 110 Risk Ratio (M-H, Fixed, 95% CI) 1.11 [0.26, 4.73]
10 Apgar score 5 min. 7 dich. 1 200 Risk Ratio (M-H, Fixed, 95% CI) 9.0 [0.49, 165.00]
11 Apgar score 5 min.cont. 1 509 Mean Difference (IV, Fixed, 95% CI) 0.0 [-0.13, 0.13]
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Comparison 5. Inhaled analgesia versus TENS
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Satisfaction pain relief first
period ordinal partial to
complete
1 20 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.29, 1.07]
2 Pain intensity first period ordinal
moderate to severe
1 19 Risk Ratio (M-H, Fixed, 95% CI) 1.1 [0.84, 1.45]
Analysis 1.1. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 1 Pain intensity (VAS 0-100
first stage).
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 1 Pain intensity (VAS 0-100 first stage)
Study or subgroup Nitrous oxide -Fluranegroup
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
McGuinness 1984 10 53 (12.5) 10 48 (16.5) 34.2 % 5.00 [ -7.83, 17.83 ]
McLeod 1985 16 63 (17) 16 46.6 (16.75) 37.9 % 16.40 [ 4.71, 28.09 ]
Wee 1993 11 74.6 (17.8) 7 51.4 (14.8) 27.9 % 23.20 [ 8.01, 38.39 ]
Total (95% CI) 37 33 100.0 % 14.39 [ 4.41, 24.37 ]
Heterogeneity: Tau2 = 32.85; Chi2 = 3.46, df = 2 (P = 0.18); I2 =42%
Test for overall effect: Z = 2.83 (P = 0.0047)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours Nitrous oxide Favours Flurane-group
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Analysis 1.2. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 2 Pain relief (VAS 0-100 as
100 is the most pain relief, first stage).
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 2 Pain relief (VAS 0-100 as 100 is the most pain relief, first stage)
Study or subgroup Nitrous oxide -Fluranegroup
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Arora 1992 19 58 (15) 20 70 (15) 60.7 % -12.00 [ -21.42, -2.58 ]
Yeo 2007 15 51 (21.75) 16 74 (16.75) 39.3 % -23.00 [ -36.73, -9.27 ]
Total (95% CI) 34 36 100.0 % -16.32 [ -26.85, -5.79 ]
Heterogeneity: Tau2 = 24.42; Chi2 = 1.68, df = 1 (P = 0.20); I2 =40%
Test for overall effect: Z = 3.04 (P = 0.0024)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours flurane-group Favours nitrous oxide
Analysis 1.3. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 3 Satisfaction with pain relief
(first and second stage, considerable to complete).
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 3 Satisfaction with pain relief (first and second stage, considerable to complete)
Study or subgroup Nitrous oxide -Fluranegroup Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Jones 1969 19/24 19/24 47.5 % 1.00 [ 0.75, 1.34 ]
Jones 1969a 20/25 21/25 52.5 % 0.95 [ 0.73, 1.24 ]
Total (95% CI) 49 49 100.0 % 0.98 [ 0.80, 1.18 ]
Total events: 39 (Nitrous oxide), 40 (-Fluranegroup)
Heterogeneity: Chi2 = 0.06, df = 1 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 0.26 (P = 0.80)
Test for subgroup differences: Not applicable
0.02 0.1 1 10 50
Favours Flurane-group Favours Nitrous oxide
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Analysis 1.4. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 4 Satisfaction with pain relief
(second stage, good to excellent).
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 4 Satisfaction with pain relief (second stage, good to excellent)
Study or subgroup Nitrous oxide -Fluranegroup Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abboud 1981 38/50 49/55 37.3 % 0.85 [ 0.71, 1.02 ]
Abboud 1995 25/40 25/40 20.0 % 1.00 [ 0.71, 1.40 ]
Belfrage 1974 33/51 34/47 28.3 % 0.89 [ 0.68, 1.17 ]
Stefani 1982 13/18 20/22 14.4 % 0.79 [ 0.58, 1.09 ]
Total (95% CI) 159 164 100.0 % 0.89 [ 0.78, 1.01 ]
Total events: 109 (Nitrous oxide), 128 (-Fluranegroup)
Heterogeneity: Chi2 = 1.12, df = 3 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 1.81 (P = 0.071)
Test for subgroup differences: Not applicable
0.02 0.1 1 10 50
Favours flurane-group Favours nitrous oxide
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Analysis 1.5. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 5 Assisted vaginal birth.
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 5 Assisted vaginal birth
Study or subgroup Nitrous oxide -Fluranegroup Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Abboud 1981 18/50 18/55 35.0 % 1.10 [ 0.65, 1.87 ]
Abboud 1995 5/40 9/40 17.0 % 0.56 [ 0.20, 1.51 ]
Belfrage 1974 3/51 4/47 9.6 % 0.69 [ 0.16, 2.93 ]
Jones 1969 5/24 5/24 14.7 % 1.00 [ 0.33, 3.01 ]
Stefani 1982 5/18 17/22 23.7 % 0.36 [ 0.17, 0.78 ]
Total (95% CI) 183 188 100.0 % 0.71 [ 0.44, 1.15 ]
Total events: 36 (Nitrous oxide), 53 (-Fluranegroup)
Heterogeneity: Tau2 = 0.10; Chi2 = 6.08, df = 4 (P = 0.19); I2 =34%
Test for overall effect: Z = 1.38 (P = 0.17)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours N2O Favours Flurane-group
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Analysis 1.6. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 6 Caesarean section.
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 6 Caesarean section
Study or subgroup Nitrous oxide -Fluranegroup Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Belfrage 1974 0/51 0/47 0.0 [ 0.0, 0.0 ]
Total (95% CI) 51 47 0.0 [ 0.0, 0.0 ]
Total events: 0 (Nitrous oxide), 0 (-Fluranegroup)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours N2O Favours Flurane group
Analysis 1.7. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 7 Amnesia.
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 7 Amnesia
Study or subgroup Nitrous oxide -Fluranegroup Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Abboud 1981 5/50 4/55 40.2 % 1.38 [ 0.39, 4.84 ]
Abboud 1995 0/40 9/40 26.5 % 0.05 [ 0.00, 0.87 ]
Swart 1991 1/30 8/30 33.4 % 0.13 [ 0.02, 0.94 ]
Total (95% CI) 120 125 100.0 % 0.26 [ 0.03, 2.38 ]
Total events: 6 (Nitrous oxide), 21 (-Fluranegroup)
Heterogeneity: Tau2 = 2.76; Chi2 = 7.62, df = 2 (P = 0.02); I2 =74%
Test for overall effect: Z = 1.19 (P = 0.23)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours N2O Favours flurane group
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Analysis 1.8. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 8 Drowsiness (VAS 0-100
mm).
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 8 Drowsiness (VAS 0-100 mm)
Study or subgroup -Fluranegroup Nitrous oxide
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Wee 1993 8 83.14 (24.12) 10 71.5 (35.6) 100.0 % 11.64 [ -16.04, 39.32 ]
Total (95% CI) 8 10 100.0 % 11.64 [ -16.04, 39.32 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
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Analysis 1.9. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 9 Nausea.
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 9 Nausea
Study or subgroup Nitrous oxide -Fluranegroup Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Jones 1969 8/24 2/24 80.0 % 4.00 [ 0.95, 16.92 ]
Jones 1969a 8/25 0/25 20.0 % 17.00 [ 1.03, 279.53 ]
Total (95% CI) 49 49 100.0 % 6.60 [ 1.85, 23.52 ]
Total events: 16 (Nitrous oxide), 2 (-Fluranegroup)
Heterogeneity: Chi2 = 0.90, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 2.91 (P = 0.0036)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours N2O Favours Flurane-group
Analysis 1.10. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 10 Vomiting.
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 10 Vomiting
Study or subgroup Nitrous oxide -Fluranegroup Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abboud 1981 1/50 0/55 9.6 % 3.29 [ 0.14, 79.06 ]
Jones 1969 6/24 4/24 80.4 % 1.50 [ 0.48, 4.65 ]
Jones 1969a 2/25 0/25 10.0 % 5.00 [ 0.25, 99.16 ]
Total (95% CI) 99 104 100.0 % 2.02 [ 0.75, 5.46 ]
Total events: 9 (Nitrous oxide), 4 (-Fluranegroup)
Heterogeneity: Chi2 = 0.71, df = 2 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.39 (P = 0.16)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours N2O Favours Flurane group
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Analysis 1.11. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 11 Blood loss in mL.
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 11 Blood loss in mL
Study or subgroup Nitrous oxide -Fluranegroup
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Abboud 1981 50 327 (91.92) 55 321 (111.3) 6.00 [ -32.91, 44.91 ]
Abboud 1995 40 364 (0) 40 335 (0) 0.0 [ 0.0, 0.0 ]
Total (95% CI) 90 95 6.00 [ -32.91, 44.91 ]
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.30 (P = 0.76)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 12 Apgar score less than
seven at five minutes.
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 12 Apgar score less than seven at five minutes
Study or subgroup Nitrous oxide -Fluranegroup Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abboud 1981 0/50 2/55 0.22 [ 0.01, 4.47 ]
Abboud 1995 0/40 0/40 0.0 [ 0.0, 0.0 ]
Belfrage 1974 0/51 0/47 0.0 [ 0.0, 0.0 ]
Cheng 2001 0/25 0/25 0.0 [ 0.0, 0.0 ]
Stefani 1982 0/18 0/22 0.0 [ 0.0, 0.0 ]
Total (95% CI) 184 189 0.22 [ 0.01, 4.47 ]
Total events: 0 (Nitrous oxide), 2 (-Fluranegroup)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.99 (P = 0.32)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Nitrous oxide versus flurane derivatives, Outcome 13 NACS < 35 at 2 hours
after delivery.
Review: Inhaled analgesia for pain management in labour
Comparison: 1 Nitrous oxide versus flurane derivatives
Outcome: 13 NACS < 35 at 2 hours after delivery
Study or subgroup Nitrous oxide -Fluranegroup Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abboud 1995 7/40 4/40 20.8 % 1.75 [ 0.56, 5.51 ]
Cheng 2001 11/25 8/25 41.7 % 1.38 [ 0.67, 2.83 ]
Stefani 1982 9/18 8/22 37.5 % 1.38 [ 0.67, 2.83 ]
Total (95% CI) 83 87 100.0 % 1.45 [ 0.91, 2.33 ]
Total events: 27 (Nitrous oxide), 20 (-Fluranegroup)
Heterogeneity: Chi2 = 0.15, df = 2 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 1.55 (P = 0.12)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours N2O Favours Flurane group
Analysis 2.1. Comparison 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength,
Outcome 1 Satisfaction with pain relief (first stage, good to complete).
Review: Inhaled analgesia for pain management in labour
Comparison: 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength
Outcome: 1 Satisfaction with pain relief (first stage, good to complete)
Study or subgroup N2O 50% N2O 70% Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
MRC 1970 194/259 173/242 100.0 % 1.05 [ 0.94, 1.17 ]
Total (95% CI) 259 242 100.0 % 1.05 [ 0.94, 1.17 ]
Total events: 194 (N2O 50%), 173 (N2O 70%)
Heterogeneity: not applicable
Test for overall effect: Z = 0.86 (P = 0.39)
Test for subgroup differences: Not applicable
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Favours N2O 70% Favours N2O 50%
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Analysis 2.2. Comparison 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength,
Outcome 2 Satisfaction with pain relief (second stage, good to complete).
Review: Inhaled analgesia for pain management in labour
Comparison: 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength
Outcome: 2 Satisfaction with pain relief (second stage, good to complete)
Study or subgroup N2O 50% N2O 70% Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
MRC 1970 184/259 177/242 100.0 % 0.97 [ 0.87, 1.08 ]
Total (95% CI) 259 242 100.0 % 0.97 [ 0.87, 1.08 ]
Total events: 184 (N2O 50%), 177 (N2O 70%)
Heterogeneity: not applicable
Test for overall effect: Z = 0.52 (P = 0.60)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength,
Outcome 3 Caesarean section.
Review: Inhaled analgesia for pain management in labour
Comparison: 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength
Outcome: 3 Caesarean section
Study or subgroup N2O 50% N2O 70% Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
MRC 1970 2/259 6/242 100.0 % 0.31 [ 0.06, 1.53 ]
Total (95% CI) 259 242 100.0 % 0.31 [ 0.06, 1.53 ]
Total events: 2 (N2O 50%), 6 (N2O 70%)
Heterogeneity: not applicable
Test for overall effect: Z = 1.44 (P = 0.15)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours N2O 50% Favours N2O 70%
Analysis 2.4. Comparison 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength,
Outcome 4 Assisted vaginal birth.
Review: Inhaled analgesia for pain management in labour
Comparison: 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength
Outcome: 4 Assisted vaginal birth
Study or subgroup N2O 50% N2O 70% Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
MRC 1970 57/259 64/242 100.0 % 0.83 [ 0.61, 1.14 ]
Total (95% CI) 259 242 100.0 % 0.83 [ 0.61, 1.14 ]
Total events: 57 (N2O 50%), 64 (N2O 70%)
Heterogeneity: not applicable
Test for overall effect: Z = 1.16 (P = 0.25)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 2.5. Comparison 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength,
Outcome 5 Vomiting.
Review: Inhaled analgesia for pain management in labour
Comparison: 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength
Outcome: 5 Vomiting
Study or subgroup N2O 50% N2O 70% Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
MRC 1970 47/259 34/242 100.0 % 1.29 [ 0.86, 1.94 ]
Total (95% CI) 259 242 100.0 % 1.29 [ 0.86, 1.94 ]
Total events: 47 (N2O 50%), 34 (N2O 70%)
Heterogeneity: not applicable
Test for overall effect: Z = 1.24 (P = 0.22)
Test for subgroup differences: Not applicable
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Analysis 2.6. Comparison 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength,
Outcome 6 Postpartum haemorrhage.
Review: Inhaled analgesia for pain management in labour
Comparison: 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength
Outcome: 6 Postpartum haemorrhage
Study or subgroup N2O 50% N2O 70% Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
MRC 1970 12/259 14/242 100.0 % 0.80 [ 0.38, 1.70 ]
Total (95% CI) 259 242 100.0 % 0.80 [ 0.38, 1.70 ]
Total events: 12 (N2O 50%), 14 (N2O 70%)
Heterogeneity: not applicable
Test for overall effect: Z = 0.58 (P = 0.56)
Test for subgroup differences: Not applicable
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Analysis 2.7. Comparison 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength,
Outcome 7 Hypoxaemia mother.
Review: Inhaled analgesia for pain management in labour
Comparison: 2 Inhaled analgesia of one strength versus inhaled analgesia of different strength
Outcome: 7 Hypoxaemia mother
Study or subgroup N2O 50% N2O 70% Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Einarsson 1996 1/12 1/12 100.0 % 1.00 [ 0.07, 14.21 ]
Total (95% CI) 12 12 100.0 % 1.00 [ 0.07, 14.21 ]
Total events: 1 (N2O 50%), 1 (N2O 70%)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Inhaled analgesia using one type of delivery system versus a different delivery
system, Outcome 1 Satisfaction with pain relief (first stage, considerable to complete).
Review: Inhaled analgesia for pain management in labour
Comparison: 3 Inhaled analgesia using one type of delivery system versus a different delivery system
Outcome: 1 Satisfaction with pain relief (first stage, considerable to complete)
Study or subgroup
N2O 50%
with nasal
suppl. N2O 50% no suppl. Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arthurs 1979 20/21 17/21 100.0 % 1.18 [ 0.94, 1.48 ]
Total (95% CI) 21 21 100.0 % 1.18 [ 0.94, 1.48 ]
Total events: 20 (N2O 50% with nasal suppl.), 17 (N2O 50% no suppl.)
Heterogeneity: not applicable
Test for overall effect: Z = 1.39 (P = 0.16)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours N2O 50% Favours N2O 50% with supp
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Analysis 3.2. Comparison 3 Inhaled analgesia using one type of delivery system versus a different delivery
system, Outcome 2 Caesarean section.
Review: Inhaled analgesia for pain management in labour
Comparison: 3 Inhaled analgesia using one type of delivery system versus a different delivery system
Outcome: 2 Caesarean section
Study or subgroup
Meth.
Penthrane
Analg.
Meth.Cyprane
inhaler Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Enrile 1973 1/14 0/12 100.0 % 2.60 [ 0.12, 58.48 ]
Total (95% CI) 14 12 100.0 % 2.60 [ 0.12, 58.48 ]
Total events: 1 (Meth. Penthrane Analg.), 0 (Meth.Cyprane inhaler)
Heterogeneity: not applicable
Test for overall effect: Z = 0.60 (P = 0.55)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Penthrane analg. Favours Cyprane inhaler
Analysis 3.3. Comparison 3 Inhaled analgesia using one type of delivery system versus a different delivery
system, Outcome 3 Vomiting (N2O + nasal).
Review: Inhaled analgesia for pain management in labour
Comparison: 3 Inhaled analgesia using one type of delivery system versus a different delivery system
Outcome: 3 Vomiting (N2O + nasal)
Study or subgroup N2O 50% with nasal suppl. Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arthurs 1979 11/25 6/24 100.0 % 1.76 [ 0.77, 4.00 ]
Total (95% CI) 25 24 100.0 % 1.76 [ 0.77, 4.00 ]
Total events: 11 (N2O 50%), 6 (with nasal suppl.)
Heterogeneity: not applicable
Test for overall effect: Z = 1.35 (P = 0.18)
Test for subgroup differences: Not applicable
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Analysis 3.4. Comparison 3 Inhaled analgesia using one type of delivery system versus a different delivery
system, Outcome 4 Vomiting dichotomous Penthr./Cypr..
Review: Inhaled analgesia for pain management in labour
Comparison: 3 Inhaled analgesia using one type of delivery system versus a different delivery system
Outcome: 4 Vomiting dichotomous Penthr./Cypr.
Study or subgroup Penthrane analgizer Cyprane inhaler Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Enrile 1973 0/14 0/12 0.0 [ 0.0, 0.0 ]
Total (95% CI) 14 12 0.0 [ 0.0, 0.0 ]
Total events: 0 (Penthrane analgizer), 0 (Cyprane inhaler)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours penthrane analgiz Favours cyprane inhaler
Analysis 3.5. Comparison 3 Inhaled analgesia using one type of delivery system versus a different delivery
system, Outcome 5 Postpartum haemorrhage.
Review: Inhaled analgesia for pain management in labour
Comparison: 3 Inhaled analgesia using one type of delivery system versus a different delivery system
Outcome: 5 Postpartum haemorrhage
Study or subgroup
Penthrane
analgizer
meth.
Cyprane
inhaler
meth. Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Enrile 1973 0/14 1/12 100.0 % 0.29 [ 0.01, 6.50 ]
Total (95% CI) 14 12 100.0 % 0.29 [ 0.01, 6.50 ]
Total events: 0 (Penthrane analgizer meth.), 1 (Cyprane inhaler meth.)
Heterogeneity: not applicable
Test for overall effect: Z = 0.78 (P = 0.43)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Penthrane analgizer Cyprane inhaler
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Analysis 3.6. Comparison 3 Inhaled analgesia using one type of delivery system versus a different delivery
system, Outcome 6 Mild pre-eclampsia.
Review: Inhaled analgesia for pain management in labour
Comparison: 3 Inhaled analgesia using one type of delivery system versus a different delivery system
Outcome: 6 Mild pre-eclampsia
Study or subgroup
Penthrane
inhaler
meth
Cyprane
inhaler
meth Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Enrile 1973 1/14 1/12 100.0 % 0.86 [ 0.06, 12.28 ]
Total (95% CI) 14 12 100.0 % 0.86 [ 0.06, 12.28 ]
Total events: 1 (Penthrane inhaler meth), 1 (Cyprane inhaler meth)
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Penthr. analgizer Cyprane inhaler
Analysis 3.7. Comparison 3 Inhaled analgesia using one type of delivery system versus a different delivery
system, Outcome 7 Apgar score (continuous, at 5 min.Penthr/Cypr).
Review: Inhaled analgesia for pain management in labour
Comparison: 3 Inhaled analgesia using one type of delivery system versus a different delivery system
Outcome: 7 Apgar score (continuous, at 5 min.Penthr/Cypr)
Study or subgroup
Penthrane
analgizer
meth
Cyprane
inhaler
meth
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Enrile 1973 14 9 (0.4) 10 9 (0.5) 100.0 % 0.0 [ -0.37, 0.37 ]
Total (95% CI) 14 10 100.0 % 0.0 [ -0.37, 0.37 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Not applicable
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Analysis 3.8. Comparison 3 Inhaled analgesia using one type of delivery system versus a different delivery
system, Outcome 8 Apgar score (continuous N2O/N2O with nasal suppl.).
Review: Inhaled analgesia for pain management in labour
Comparison: 3 Inhaled analgesia using one type of delivery system versus a different delivery system
Outcome: 8 Apgar score (continuous N2O/N2O with nasal suppl.)
Study or subgroup N2O
N2O with
nasal suppl.
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Arthurs 1979 25 9.3 (1.1) 24 9.6 (0.7) 100.0 % -0.30 [ -0.81, 0.21 ]
Total (95% CI) 25 24 100.0 % -0.30 [ -0.81, 0.21 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.14 (P = 0.25)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
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Analysis 4.1. Comparison 4 Inhaled analgesia versus placebo control/no treatment, Outcome 1 Pain
intensity (first stage, clear/severe to intense/extreme).
Review: Inhaled analgesia for pain management in labour
Comparison: 4 Inhaled analgesia versus placebo control/no treatment
Outcome: 1 Pain intensity (first stage, clear/severe to intense/extreme)
Study or subgroup nitrous oxide 50% no analgesia Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Ji 2002 9/100 100/100 72.4 % 0.09 [ 0.05, 0.17 ]
Zhang 2001 0/60 30/50 27.6 % 0.01 [ 0.00, 0.22 ]
Total (95% CI) 160 150 100.0 % 0.06 [ 0.01, 0.34 ]
Total events: 9 (nitrous oxide 50%), 130 (no analgesia)
Heterogeneity: Tau2 = 1.08; Chi2 = 2.03, df = 1 (P = 0.15); I2 =51%
Test for overall effect: Z = 3.14 (P = 0.0017)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours N2O 30-50% Favours control (nothing)
Analysis 4.2. Comparison 4 Inhaled analgesia versus placebo control/no treatment, Outcome 2 Pain
intensity (first stage, VAS 0-10 after 1 hour).
Review: Inhaled analgesia for pain management in labour
Comparison: 4 Inhaled analgesia versus placebo control/no treatment
Outcome: 2 Pain intensity (first stage, VAS 0-10 after 1 hour)
Study or subgroup nitrous oxide 50% O2 50%
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Talebi 2009 260 4.8 (1.6) 249 8.3 (1.3) 100.0 % -3.50 [ -3.75, -3.25 ]
Total (95% CI) 260 249 100.0 % -3.50 [ -3.75, -3.25 ]
Heterogeneity: not applicable
Test for overall effect: Z = 27.14 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 4.3. Comparison 4 Inhaled analgesia versus placebo control/no treatment, Outcome 3 Assisted
vaginal birth.
Review: Inhaled analgesia for pain management in labour
Comparison: 4 Inhaled analgesia versus placebo control/no treatment
Outcome: 3 Assisted vaginal birth
Study or subgroup N2O Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ji 2002 6/100 4/100 100.0 % 1.50 [ 0.44, 5.15 ]
Total (95% CI) 100 100 100.0 % 1.50 [ 0.44, 5.15 ]
Total events: 6 (N2O), 4 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours N2O Favours control
79Inhaled analgesia for pain management in labour (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.4. Comparison 4 Inhaled analgesia versus placebo control/no treatment, Outcome 4 Caesarean
section.
Review: Inhaled analgesia for pain management in labour
Comparison: 4 Inhaled analgesia versus placebo control/no treatment
Outcome: 4 Caesarean section
Study or subgroup
nitrous
oxide 30 to
50% no analgesia Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ji 2002 21/100 14/100 52.2 % 1.50 [ 0.81, 2.78 ]
Rezaeipour 2008 2/78 3/77 11.3 % 0.66 [ 0.11, 3.83 ]
Zhang 2001 10/60 9/50 36.6 % 0.93 [ 0.41, 2.10 ]
Total (95% CI) 238 227 100.0 % 1.20 [ 0.75, 1.91 ]
Total events: 33 (nitrous oxide 30 to 50%), 26 (no analgesia)
Heterogeneity: Chi2 = 1.34, df = 2 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 0.74 (P = 0.46)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Nitrous oxide Favour O2 or no analgesia
Analysis 4.5. Comparison 4 Inhaled analgesia versus placebo control/no treatment, Outcome 5 Vomiting.
Review: Inhaled analgesia for pain management in labour
Comparison: 4 Inhaled analgesia versus placebo control/no treatment
Outcome: 5 Vomiting
Study or subgroup N2O 30-50% O2 50-100% Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Talebi 2009 6/260 0/249 48.4 % 12.45 [ 0.71, 219.88 ]
Zhang 2001 3/60 0/50 51.6 % 5.85 [ 0.31, 110.68 ]
Total (95% CI) 320 299 100.0 % 9.05 [ 1.18, 69.32 ]
Total events: 9 (N2O 30-50%), 0 (O2 50-100%)
Heterogeneity: Chi2 = 0.13, df = 1 (P = 0.72); I2 =0.0%
Test for overall effect: Z = 2.12 (P = 0.034)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours N2O 30 to 50% Favours O2 50 to 100%
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Analysis 4.6. Comparison 4 Inhaled analgesia versus placebo control/no treatment, Outcome 6 Nausea.
Review: Inhaled analgesia for pain management in labour
Comparison: 4 Inhaled analgesia versus placebo control/no treatment
Outcome: 6 Nausea
Study or subgroup N2O 50% O2 50% Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Talebi 2009 22/260 0/249 100.0 % 43.10 [ 2.63, 706.74 ]
Total (95% CI) 260 249 100.0 % 43.10 [ 2.63, 706.74 ]
Total events: 22 (N2O 50%), 0 (O2 50%)
Heterogeneity: not applicable
Test for overall effect: Z = 2.64 (P = 0.0084)
Test for subgroup differences: Not applicable
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Analysis 4.7. Comparison 4 Inhaled analgesia versus placebo control/no treatment, Outcome 7 Dizziness.
Review: Inhaled analgesia for pain management in labour
Comparison: 4 Inhaled analgesia versus placebo control/no treatment
Outcome: 7 Dizziness
Study or subgroup N2O 50% O2 50% Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Talebi 2009 59/260 0/249 100.0 % 113.98 [ 7.09, 1833.69 ]
Total (95% CI) 260 249 100.0 % 113.98 [ 7.09, 1833.69 ]
Total events: 59 (N2O 50%), 0 (O2 50%)
Heterogeneity: not applicable
Test for overall effect: Z = 3.34 (P = 0.00083)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours N2O 50% Favours O2 50%
Analysis 4.8. Comparison 4 Inhaled analgesia versus placebo control/no treatment, Outcome 8 Drowsiness.
Review: Inhaled analgesia for pain management in labour
Comparison: 4 Inhaled analgesia versus placebo control/no treatment
Outcome: 8 Drowsiness
Study or subgroup N2O 50% O2 50% Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Talebi 2009 40/260 0/249 100.0 % 77.59 [ 4.80, 1254.96 ]
Total (95% CI) 260 249 100.0 % 77.59 [ 4.80, 1254.96 ]
Total events: 40 (N2O 50%), 0 (O2 50%)
Heterogeneity: not applicable
Test for overall effect: Z = 3.06 (P = 0.0022)
Test for subgroup differences: Not applicable
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Analysis 4.9. Comparison 4 Inhaled analgesia versus placebo control/no treatment, Outcome 9 Neonatal
asphyxia.
Review: Inhaled analgesia for pain management in labour
Comparison: 4 Inhaled analgesia versus placebo control/no treatment
Outcome: 9 Neonatal asphyxia
Study or subgroup N2O O2 Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Zhang 2001 4/60 3/50 100.0 % 1.11 [ 0.26, 4.73 ]
Total (95% CI) 60 50 100.0 % 1.11 [ 0.26, 4.73 ]
Total events: 4 (N2O), 3 (O2)
Heterogeneity: not applicable
Test for overall effect: Z = 0.14 (P = 0.89)
Test for subgroup differences: Not applicable
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